Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow, Cardiology, Duke University School of Medicine 1986 - 1988
  • Resident, Internal Medicine, Barnes Hospital 1983 - 1985
  • Intern, Internal Medicine, Barnes Hospital 1982 - 1983
  • M.D., Johns Hopkins University 1982
• 

  Medical Licensure

  • 0101058287. Virginia. 1994
  • 32586. North Carolina. 1986
• 

  Duke Appointment History

  • Associate Professor in Community and Family Medicine, Community and Family Medicine, Clinical Science Departments 2004 - 2008
  • Associate Professor of Medicine, Medicine, Cardiology, Medicine 1999 - 2007
  • Associate Professor of Medicine, Medicine, Cardiology, Medicine 1997 - 1999
  • Assistant Professor of Medicine, Medicine, Cardiology, Medicine 1990 - 1997
  • Associate in the Department of Medicine, Medicine, Clinical Science Departments 1988 - 1989
• 

  Leadership & Clinical Positions at Duke

  • Chair, Clinical Appointment, Promotions, and Tenure Committee: 7/2017 - present
    Chair, Interventional Cardiology Clinical Competency Committee: 7/2015 - present
    Chief Medical Information Officer, Duke Heart Network: 7/2015 - present
    Director, Biomedical Informatics, Duke Translational Medicine Institute: 11/2008-8/2012
    Medical Knowledge Architect, Duke University Health System: 2004-2010
    Director, Performance Improvement, Division of Cardiology: 1994-present
    Director, Duke Information Systems for Cardiovascular Care: 1993-present
• Recognition
• 

  Awards & Honors

  • Distinguished Service. American College of Cardiology. March 2018
  • Master Clinician / Teacher. Duke University Health System. May 2015
  • Strength, Hope and Caring. Duke University Health System. November 2004
• Expertise
• 

  Subject Headings

  • Angioplasty
  • Coronary Angiography
  • Coronary Artery Disease
  • Informatics
  • Stents
• 

  Global Scholarship

  • Expertise

    • United States of America 
• Research
• 

  Selected Grants

  • Improvement of interoperability of healthcare data awarded by Pew Charitable Trusts 2018
  • Building UDI Into Longitudinal Data for Medical Device Evaluation (BUILD) awarded by Mercy Health 2018
  • Optimizing the Electronic Health Record for Cardiac Care awarded by University of Nebraska 2014 - 2018
  • BUILD awarded by Mercy Health 2016 - 2017
  • MEDpiNET awarded by Food and Drug Administration 2013 - 2017
  • Population-based Surveillance And Outcomes of Venous Thromboembolism awarded by Centers for Disease Control and Prevention 2012 - 2015
  • Standardized Collection and Submission of Cardiovascular Endpoint Data awarded by Food and Drug Administration 2012 - 2013
  • Data Concepts and Terminology Standards in Cardiovascular Imaging (R24) awarded by Food and Drug Administration 2012 - 2013
  • Synthesis and Harmonization of High Impact Data Elements awarded by Food and Drug Administration 2011 - 2013
  • CTSA UL awarded by National Institutes of Health 2006 - 2012
• Publications & Artistic Works
• 

  Selected Publications

  • Books

    • Watson, TJ, Ong, PJL, and Tcheng, JE. Primary Angioplasty A Practical Guide. : Springer, July 13, 2018.
    • Tcheng, JE. Optimizing Strategies for Clinical Decision Support Summary of a Meeting Series. 2017.
    • Tcheng, J. Primary Angioplasty in Acute Myocardial Infarction. Humana Press, October 28, 2010.
    • Tcheng, JE. Primary Angioplasty in Acute Myocardial Infarction. : Springer Science & Business Media, 2002.

  • Book Sections

    • Tcheng, JE, and Cox, DA. "Primary Coronary Intervention: The Technical Approach." In Primary Angioplasty in Acute Myocardial Infarction, 47-47. Springer Science & Business Media, April 29, 2009. (Chapter)

  • Conference Papers

    • Tcheng, JE, Kawamoto, K, Middleton, B, Teich, JM, and Weingarten, S. "Optimizing Patient Care through Clinical Decision Support: Identification of Opportunities and Call to Action by the National Academy of Medicine." AMIA, 2017.
    • Tcheng, JE, Crowley, J, Tomes, M, Reed, TL, Dudas, JM, Thompson, KP, Garratt, KN, and Drozda, JP. "Unique device identifiers for coronary stent postmarket surveillance and research: A report from the Food and Drug Administration Medical Device Epidemiology Network Unique Device Identifier Demonstration." January 1, 2014.  Full Text
    • Denardo, SJ, Carpinone, PL, Vock, DM, Tcheng, JE, III, PHR, Batich, CD, and Pepine, CJ. "DAMAGE TO POLYMER SURFACE AND DETACHMENT OF POLYMER FRAGMENTS DURING DELIVERY BALLOON EXPANSION OF DRUG-ELUTING STENTS: A PREVIOUSLY UNRECOGNIZED SOURCE FOR ADVERSE OUTCOMES." March 27, 2012.  Full Text  Link to Item
    • Mehta, RH, Harjai, KJ, Boura, JA, Tcheng, JE, Stone, GW, and Grines, CL. "Is Balloon Angioplasty without Stent Placement Adequate far Patients In Whom Early Coronary Artery Bypass Surgery Is Planned after Primary Percutaneous Coronary Intervention?." October 28, 2008.  Link to Item
    • Dery, J-P, Griffin, J, Pieper, KS, Harrington, RA, and Tcheng, JE. "Comparison of outcomes between patients undergoing percutaneous coronary stent implantation with eptifibatide and abciximab: An analysis using propensity score methods." October 20, 2007.  Link to Item
    • Rabbani, LE, Stant, J, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Mehran, R, and Stone, GW. "Impact of thienopyridine administration prior to primary stealing in acute myocardial infarction." October 20, 2007.  Link to Item
    • Deibele, AJ, Jennings, LK, Kirtane, AJ, Pinto, DS, Slovut, DP, Lucca, MJ, Neva, C, Tcheng, JE, and Gibson, CM. "Local platelet glycoprotein IIb/IIIa receptor occupancy with intracoronary eptitibatide during stenting, the ICE pilot trial." October 22, 2006.  Link to Item
    • Denardo, J, Davis, KE, and Tcheng, JE. "Low dose enoxaparin in non-ST segment elevation acute coronary syndrome, followed by antiplatelet therapy alone during subsequent percutaneous coronary intervention." August 2006.  Link to Item
    • Halabi, AR, Honeycutt, EF, Stebbins, AL, Mehta, RH, Sketch, MH, Peterson, ED, Pieper, KS, Shaw, LK, Califf, RM, Tcheng, JE, and Harrington, RA. "A contemporary risk score for the prediction of long-term mortality following percutaneous coronary intervention with stent implantation: The duke PCI risk score." October 25, 2005.  Link to Item
    • Nikolsky, E, Mehran, R, Grines, CL, Turco, M, Park, T, Cox, DA, Tcheng, JE, Brodie, BR, Guagliumi, G, Griffin, JJ, Acdo, T, Kodali, S, Lansky, AJ, Negoita, M, and Stone, GW. "Higher baseline platelet count predicts reinfarction and death in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial." October 25, 2005.  Link to Item
    • Simon, DI, Burton, P, Palabrica, T, and Tcheng, JE. "Impact of eptifibatide therapy on outcome in patients undergoing multiple stent insertion: An ESPRIT subanalysis." October 25, 2005.  Link to Item
    • Nikolsky, E, Mehran, R, Grines, CL, Turco, M, Cox, DA, Tcheng, JE, Brodie, BR, Guagliumi, G, Griffin, JJ, Lansky, AJ, Negoita, M, Mercado, DJ, Addo, T, and Stone, GW. "Impact of baseline platelet count on outcomes of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial." October 17, 2005.  Link to Item
    • De Luca, G, Suryapranata, H, Stone, GW, Antoniucci, D, Tcheng, JE, Neumann, FJ, Van de Werf, F, Antman, EM, and Topol, EJ. "Adjunctive abciximab to reperfusion therapy in patients with acute st-segment elevation myocardial infarction: A meta-analysis of randomized trials." February 1, 2005.  Link to Item
    • Nikolsky, E, Grines, CL, Cox, DA, Stuckey, T, Garcia, E, Guagliumi, G, Tcheng, JE, Mehran, R, Negoita, M, Sikand, R, Lansky, AJ, and Stone, GW. "Stroke after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial." February 1, 2005.  Link to Item
    • Nikolsky, E, Singh, M, Grines, CL, Tcheng, JE, Garcia, E, Cox, DA, Turco, M, Stuckey, TD, Na, Y, Lansky, AJ, Gersh, BJ, O'Neil, WW, Mehran, R, and Stone, GW. "Prediction of mortality following primary percutaneous coronary intervention for acute myocardial infarction: The CADILLAC risk score." February 1, 2005.  Link to Item
    • Tsuchiya, Y, Lansky, AJ, Mehran, R, Costa, RA, Cristea, E, Tarawali, M, Corral, M, Pietras, C, Na, YB, Siegel, R, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Carroll, JD, Rutherford, BD, and Stone, GW. "Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction. Results from the CADILLAC trial." February 1, 2005.  Link to Item
    • Sorajja, P, Lansky, A, Tcheng, JE, Costantini, CO, McLaughlin, M, Grines, CL, Zimetbaum, P, and Gersh, BJ. "Integration of ST-segment recovery and myocardial blush for prediction of survival after primary percutaneous coronary intervention in acute myocardial infarction." October 26, 2004.  Link to Item
    • Sorajja, P, Tcheng, JE, Guagliumi, G, Turco, MA, Carroll, JD, Brodie, B, Garcia, E, Grines, CL, Cox, DA, and Gersh, BJ. "Adverse impact of multivessel disease on ST-segment recovery and clinical outcome in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction." October 26, 2004.  Link to Item
    • Halkin, A, Turco, M, Cox, DA, Stuckey, TD, Garcia, E, Guagliumi, G, Mehran, R, Rutherford, BD, Griffin, JJ, Tcheng, JE, Grines, CL, and Stone, GW. "Outcomes of percutaneous coronary intervention in patients with acute myocardial infarction excluded from randomization: The CADILLAC Trial." September 30, 2004.  Link to Item
    • Kandzari, DE, Cox, DA, Stuckey, T, Turco, M, Mehran, R, Gersh, BJ, Garcia, E, Zimmetbaum, P, McGlaughlin, M, Lansky, AJ, Grines, CL, Tcheng, JE, and Stone, GW. "Reperfusion success and prognosis in patients with anterior compared with nonanterior infarction: Insights from the CADILLAC trial." September 30, 2004.  Link to Item
    • Nikolsky, E, Grines, CL, Cox, DA, Garcia, E, Mehran, R, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Cohen, DA, Negoita, M, Halkin, A, Weisz, G, Na, Y, Slack, S, and Lansky, AJ. "Implications of stroke after primary angioplasty in acute myocardial infarction." September 30, 2004.  Link to Item
    • Sorajja, P, Gersh, BJ, Cox, DA, Turco, MA, Tcheng, JE, Carroll, JD, Brodie, B, Garcia, E, Guagliumi, G, Grines, CL, and Stone, GW. "Adverse impact of multivessel disease on ST-segment recovery and clinical outcome in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction." September 30, 2004.  Link to Item
    • Sorajja, P, Lansky, A, Grines, CL, Costantini, C, McLaughlin, MG, Tcheng, JE, Gersh, BJ, and Stone, GW. "Prediction of survival after primary percutaneous coronary intervention by integration of ST-segment recovery and myocardial blush." September 30, 2004.  Link to Item
    • Denardo, JS, Davis, KE, and Tcheng, JE. "Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy." March 3, 2004.  Link to Item
    • Halkin, A, Grines, GL, Cox, DA, Garcia, E, Mehran, R, Tcheng, JE, Griffin, JJ, Guagliumi, G, Brodie, B, Turco, M, Rutherford, BD, Aymong, EA, Lansky, AJ, and Stone, GW. "Impact of intravenous beta-blockade during primary percutaneous intervention on convalescent left ventricular function." March 3, 2004.  Full Text  Link to Item
    • Nikolsky, E, Halkin, A, Aymong, EA, Mehran, R, Lansky, A, Grines, CL, Turco, M, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Cohen, DA, Rutherford, BD, and Stone, GW. "Anemia worsens prognosis after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial." March 3, 2004.  Full Text  Link to Item
    • Nikolsky, E, Mehran, R, Lansky, AJ, Grines, GL, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Cohen, DA, Rutherford, B, and Stone, GW. "Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction: The obesity paradox." March 3, 2004.  Full Text  Link to Item
    • Pellizzon, GG, Marso, SP, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Carroll, JD, Lansky, AJ, Mehran, R, Rutherford, BD, and Stone, GW. "Predictors of reinfarction after ST elevation myocardial infarction and glycoprotein receptor blockade: Analysis from the CADILLAC trial." March 3, 2004.  Full Text  Link to Item
    • Dery, JP, Campbell, ME, O'Shea, JC, Mathias, J, Pieper, K, Hafley, G, Kottmeyer, L, Greenberg, S, and Tcheng, JE. "Administration of a loading dose amplifies the beneficial effect of thienopyridine pretreatment and complements the use of GP IIb/IIIa inhibitor therapy in patients undergoing percutaneous coronary intervention with stenting." October 28, 2003.  Link to Item
    • Exaire, JE, Tcheng, JE, Kereiakes, DJ, Kleiman, NS, Applegate, RJ, and Moliterno, DJ. "Closure devices and vascular complications among PCI patients receiving enoxaparin, GP Ilb/Illa inhibitors and clopidogrel: Insight from ELECT." October 28, 2003.  Link to Item
    • Halkin, A, Aymong, E, Nikolsky, E, Tcheng, JE, Rutherford, BD, Costantini, C, Grines, CL, and Stone, GW. "Marked survival benefit of peri-procedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty not previously treated with beta-blockers." October 28, 2003.  Link to Item
    • Halkin, A, Rutherford, BD, Garcia, E, Fahy, M, and Tcheng, JE. "Predictors of left ventricular ejection fraction following primary percutaneous intervention for acute myocardial infarction." October 28, 2003.  Link to Item
    • Harrison, JK, Hermiller, JB, Vetrovec, GW, Smith, JE, Pulsipher, MW, Kern, MJ, Conn, EH, Navetta, FI, She, L, Pieper, K, Sketch, MH, Tcheng, JE, and Davidson, CJ. "A randomized study of 1276 patients undergoing PCI using iodixanol (Visipaque) vs iopamidol (Isovue); Comparison of in-hospital and 30 day major adverse cardiac events. The results of the VICC trial." October 28, 2003.  Link to Item
    • Prasad, A, Stone, G, Aymong, E, Zimetbaum, PJ, McLaughlin, M, Mehran, R, Garcia, E, Tcheng, JE, Cox, DA, Grines, C, and Gersh, BJ. "Impact of ST-segment resolution following primary angioplasty on outcomes after myocardial infarction in the elderly: An analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial." October 28, 2003.  Link to Item
    • Aymong, E, Fahy, M, Lansky, A, Mehran, R, Grines, CL, Cox, DA, Garcia, CE, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, and Stone, GW. "Can stents and glycoprotein IIb/IIIa inhibitors improve the prognosis of young patients with acute myocardial infarction? A report from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) study." September 15, 2003.  Link to Item
    • Costa, RA, Tsuchiya, Y, Tarawali, M, Marginean, H, Sanchez, R, Cristea, E, Mehran, R, Stuckey, T, Guagluimi, G, Cox, DA, Tcheng, JE, Carroll, JD, Griffen, JJ, Grines, CL, Lansky, AJ, and Stone, GW. "Impact of age on the outcomes of women with acute myocardial infarction undergoing primary coronary stenting." September 15, 2003.  Link to Item
    • Costantini, CO, Lansky, AJ, Costa, RA, Mehran, R, Aymong, E, Cox, DA, Tcheng, JE, Stuckey, T, Carroll, JD, Garcia, E, Guagliumi, G, Fahy, M, Griffen, JJ, Grines, CL, and Stone, GW. "Impact of myocardial blush analysis methodologies in predicting short and long-term mortality after primary angioplasty. The CADILLAC trial." September 15, 2003.  Link to Item
    • Costantini, CO, Marginea, H, Cristea, E, Tsyshiya, Y, Costa, RA, Stuckey, T, Turco, M, Guagliumi, G, Cox, DA, Tcheng, JE, Grines, CL, Griffin, JJ, Lansky, AJ, and Stone, GW. "Are there any angiographic predictors of abciximab benefit after primary angioplasty for acute myocardial infarction? Analysis from the CADILLAC trial." September 15, 2003.  Link to Item
    • Halkin, A, Nikolsky, E, Aymong, E, Mehran, R, Tcheng, JE, Cox, DA, Stuckey, T, Lansky, AJ, and Stone, GW. "The survival benefit of periprocedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty is determined by use of these drugs before admission." September 15, 2003.  Link to Item
    • Harjai, KJ, Grines, CL, Stone, GW, Lansky, AJ, Aymong, E, Fahy, M, Cox, DA, Garcia, E, Tcheng, JE, Griffins, JJ, Guagliumi, G, Stuckey, T, Turco, M, Rutherford, BD, Carroll, JD, and Brodie, BR. "Does the use of heparin after primary angioplasty for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa antagonists alleviate recurrent cardiac ischemia? Insights from the CADILLAC study." September 15, 2003.  Link to Item
    • Kandzari, DE, Labinaz, M, Cantor, WJ, Gallup, DS, Hasselblad, V, Joseph, D, Allen, A, Green, C, Hidinger, KG, Krucoff, MW, Christenson, RH, Harrington, RA, and Tcheng, JE. "Reduction of ischemic injury following coronary intervention: Results of the MC-1 to eliminate necrosis and damage trial (MEND-1)." September 15, 2003.  Link to Item
    • Nikolsky, E, Aymong, E, Lansky, AJ, Stone, GW, Turco, M, Cox, DA, Tcheng, JE, Stuckey, T, Carrol, JD, Griffins, JJ, and Grines, CL. "Anemia worsens prognosis after primary Angioplasty in acute myocardial infarction: Analysis from the cadillac study." September 15, 2003.  Link to Item
    • Rebeiz, AG, Campbell, ME, Toffaletti, JG, McDonnell, EH, Sketch, MH, and Tcheng, JE. "Activated clotting time values measured with the actalyke machine are consistently lower than measurements obtained with the Hemochron-801." September 15, 2003.  Link to Item
    • Sadeghi, HM, Grines, CL, Mehran, R, Lansky, AJ, Fahy, M, Cox, DA, Tcheng, JE, Dixon, SR, Griffin, JJ, Stuckey, TD, Brodie, BR, Turco, M, Carroll, JD, and Stone, GW. "Incidence and implications of in-hospital acquired thromhocytopenia in patients undergoing primary angioplasty for acute myocardial infarction." September 15, 2003.  Link to Item
    • Stuckey, TD, Grines, CL, Cox, DA, Brodie, BR, Turco, M, Zimetbaum, P, Tcheng, JE, Garcia, E, Griffin, JJ, Guagliumi, G, Mehran, RA, Aymong, E, and Stone, GW. "Does stenting and glycoprotein IIb/IIIa receptor blockade improve ST segment recovery and outcome in patients undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial." September 15, 2003.  Link to Item
    • Vagaonescu, TD, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Carroll, JD, Rutherford, BD, Fahy, M, Costantini, C, Mehran, R, and Stone, GW. "Does treatment with abciximab influence survival in patients with acute myocardial infarction and elevated baseline white blood cell count undergoing primary angioplasty? The CADILLAC trial." September 15, 2003.  Link to Item
    • Lowe, R, Lamas, GA, Kandzari, DE, Tcheng, JE, Knatterud, G, Mancini, GBJ, White, H, Col, J, Dzavik, V, Forman, S, Hochman, J, and Buller, CE. "Does ventricular geometry simply measure ejection fraction? An analysis from the occluded artery trial (OAT)." May 2003.  Link to Item
    • Ashby, DT, Tcheng, JE, Grines, CL, Cox, DA, Mehran, R, Fahy, MP, Garcia, E, Griffin, JJ, Guagliumi, G, Stuckey, TD, Turco, M, Lansky, AJ, and Stone, GW. "Outcomes in patients requiring bail-out abciximab during primary intervention in acute myocardial infarction: Analysis from the CADILLAC trial." March 19, 2003.  Link to Item
    • Aymong, ED, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, TD, Turco, M, Carroll, JD, Rutherford, BD, Lansky, AJ, Mehran, R, and Stone, GW. "Predictors and sequelae of subacute thrombosis after percutaneous intervention in acute myocardial infarction: The CADILLAC trial." March 19, 2003.  Link to Item
    • Aymong, ED, McLaughlin, MG, Zimetbaum, P, Grines, CL, Tcheng, JE, Cox, DA, Stuckey, TD, Turco, M, Garcia, E, Griffin, JJ, Mehran, R, Stone, GW, and Investigators, CADILLAC. "Prognostic value of the absolute degree of ST-segment elevation of the ECG at baseline and after primary angioplasty: Analysis from the CADILLAC trial." March 19, 2003.  Link to Item
    • Brodie, BR, Cox, DA, Stuckey, TD, Turco, M, Garcia, E, Griffin, JJ, Fahy, M, Tcheng, JE, Grines, CL, Mehran, R, and Stone, GW. "How important is time to treatment with primary percutaneous coronary intervention for acute myocardial infarction? Results from the CADILLAC trial." March 19, 2003.  Link to Item
    • Brodie, BR, Gersh, B, Stuckey, TD, Zimetbaum, P, McLaughlin, MG, Aymong, ED, Mehran, R, O'Neill, B, Tcheng, JE, Turco, M, Cox, DA, Grines, CL, and Stone, GW. "Relationship between time to treatment, electrocardiographic ST-segment resolution, and outcomes with primary percutaneous coronary intervention for acute myocardial infarction: Results from the CADILLAC trial." March 19, 2003.  Link to Item
    • Dery, JP, Braden, GA, Lincoff, AM, Kereiakes, DJ, Browne, KF, Little, T, George, BS, Effron, MB, Mascelli, MA, Langrall, MA, Damaraju, L, Barnathan, ES, and Tcheng, JE. "Abciximab readministration: Final results of the Reopro(fi) read ministration registry." March 19, 2003.  Link to Item
    • Kandzari, DE, Hasselblad, V, Tcheng, JE, Stone, GW, Califf, RM, Brener, SJ, Montalescot, G, Neumann, FJ, Kastrati, A, and Harrington, RA. "Improved clinical outcomes with abciximab therapy in acute myocardial infarction: A systematic overview of randomized clinical trials." March 19, 2003.  Link to Item
    • Kandzari, DE, Tcheng, JE, Grines, CL, Cohen, DJ, Bakhai, A, Cox, DA, Stuckey, TD, Effron, M, Griffin, JJ, Turco, M, Carroll, JD, Fahy, M, Mehran, R, and Stone, GW. "Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trial." March 19, 2003.  Link to Item
    • Kandzari, DE, Tcheng, JE, Grines, CL, Effron, M, Cox, DA, Garcia, E, Griffin, JJ, Guagliumi, G, Stuckey, TD, Turco, M, Lansky, AJ, Mehran, R, and Stone, GW. "Benefits and risks of abciximab use in primary Angioplasty for acute myocardial infarction: The CADILLAC trial." March 19, 2003.  Link to Item
    • McLaughlin, MG, Gardner, G, Aymong, ED, Mehran, R, Lansky, AJ, Grines, CL, Tcheng, JE, Cox, DA, Stuckey, TD, Garcia, E, Guagliumi, G, Turco, M, Zimetbaum, P, and Stone, GW. "ST-segment elevation resolution as a predictor of mortality in patients with thrombolysis in myocardial infarction III flow in the infarct artery after primary angioplasty: The CADILLAC trial." March 19, 2003.  Link to Item
    • Sadeghi, HM, Grines, CL, Mehran, R, Chandra, HR, Fahy, M, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, TD, Turco, M, Carroll, JD, Rutherford, BD, and Stone, GW. "Magnitude and impact of after hours treatment delay in patients undergoing primary Angioplasty for acute myocardial infarction: The CADILLAC trial." March 19, 2003.  Link to Item
    • Sadeghi, HM, Grines, CL, Mehran, R, Dixon, SR, Lansky, AJ, Fahy, M, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, TD, Turco, M, Carroll, JD, Rutherford, BD, and Stone, GW. "Marked mortality risk of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction." March 19, 2003.  Link to Item
    • Turco, MA, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, TD, Carroll, JD, Grines, CL, Rutherford, BD, Slack, S, Fahy, M, Mehran, R, Lansky, AJ, and Stone, GW. "Baseline features and clinical results in patients excluded from randomization from a large international trial of reperfusion strategies in acute myocardial infarction: The CADILLAC registry." March 19, 2003.  Link to Item
    • Turco, MA, Fahy, M, Mehran, RA, Lansky, A, Grines, CL, Tcheng, JE, Garcia, E, Guagliumi, G, Cox, DA, Stuckey, TD, Shaddinger, DE, and Stone, GW. "Predictors of treatment delay in patients with acute myocardial infarction undergoing primary angioplasty: An analysis from the CADILLAC trial." March 19, 2003.  Link to Item
    • Denardo, SJ, Davis, KE, and Tcheng, JE. "Elective percutaneous coronary intervention using anti-platelet therapy alone, without unfractionated heparin or other anti-thrombin therapy." 2003.  Full Text  Link to Item
    • Kong, DF, Hasselblad, V, Harrington, RA, White, HD, Tcheng, JE, Kandzari, DE, Topol, EJ, and Califf, RM. "Cumulative meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions." 2003.  Full Text  Link to Item
    • Bakhai, A, Stone, GW, Murphy, SA, Githiora, L, Berezin, RH, Gedney, S, Hormel, P, Effron, M, Cox, DA, Tcheng, JE, Grines, CL, and Cohen, DJ. "Cost-effectiveness of coronary stenting and abciximab for patients with AMI: Results from the CADILLAC trial." November 5, 2002.  Link to Item
    • Denardo, SJ, Davis, KE, and Tcheng, JE. "Adjunctive pharmacotherapy confined to an anti-platelet regimen during elective percutaneous coronary intervention." November 5, 2002.  Link to Item
    • Lansky, AJ, Costantini, C, Desai, K, Adamian, M, Cox, D, Tcheng, JE, Griffin, J, Stuckey, T, Garcia, E, Carroll, J, and Stone, GW. "Exposing the gender gap in outcomes after primary intervention for acute myocardial infarction: Results from the CADILLAC trial." November 5, 2002.  Link to Item
    • Weisz, G, Ashby, D, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, TF, Turco, M, Carroll, JD, Fahy, M, and Cox, DA. "Impact of smoking status in patients with acute myocardial infarction treated with primary percutaneous intervention: The smoker's paradox revisited." November 5, 2002.  Link to Item

  • Journal Articles

    • Hicks, KA, Mahaffey, KW, Mehran, R, Nissen, SE, Wiviott, SD, Dunn, B, Solomon, SD, Marler, JR, Teerlink, JR, Farb, A, Morrow, DA, Targum, SL, Sila, CA, Thanh Hai, MT, Jaff, MR, Joffe, HV, Cutlip, DE, Desai, AS, Lewis, EF, Gibson, CM, Landray, MJ, Lincoff, AM, White, CJ, Brooks, SS, Rosenfield, K, Domanski, MJ, Lansky, AJ, McMurray, JJV, Tcheng, JE, Steinhubl, SR, Burton, P, Mauri, L, O'Connor, CM, Pfeffer, MA, Hung, HMJ, Stockbridge, NL, Chaitman, BR, Temple, RJ, and Standardized Data Collection for Cardiovascular Trials Initiative (SCTI), . "2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials." Journal of the American College of Cardiology 71, no. 9 (March 2018): 1021-1034. (Review)  Full Text
    • Drozda, JP, Roach, J, Forsyth, T, Helmering, P, Dummitt, B, and Tcheng, JE. "Constructing the informatics and information technology foundations of a medical device evaluation system: a report from the FDA unique device identifier demonstration." Journal of the American Medical Informatics Association : JAMIA 25, no. 2 (February 2018): 111-120.  Full Text
    • Hicks, KA, Mahaffey, KW, Mehran, R, Nissen, SE, Wiviott, SD, Dunn, B, Solomon, SD, Marler, JR, Teerlink, JR, Farb, A, Morrow, DA, Targum, SL, Sila, CA, Hai, MTT, Jaff, MR, Joffe, HV, Cutlip, DE, Desai, AS, Lewis, EF, Gibson, CM, Landray, MJ, Lincoff, AM, White, CJ, Brooks, SS, Rosenfield, K, Domanski, MJ, Lansky, AJ, McMurray, JJV, Tcheng, JE, Steinhubl, SR, Burton, P, Mauri, L, O'Connor, CM, Pfeffer, MA, Hung, HMJ, Stockbridge, NL, Chaitman, BR, Temple, RJ, and Standardized Data Collection for Cardiovascular Trials Initiative (SCTI), . "2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials." Circulation 137, no. 9 (February 2018): 961-972. (Review)  Full Text
    • Jones, WS, Krucoff, MW, Morales, P, Wilgus, RW, Heath, AH, Williams, MF, Tcheng, JE, Marinac-Dabic, JD, Malone, ML, Reed, TL, Fukaya, R, Lookstein, RA, Handa, N, Aronow, HD, Bertges, DJ, Jaff, MR, Tsai, TT, Smale, JA, Zaugg, MJ, Thatcher, RJ, and Cronenwett, JL. "Registry Assessment of Peripheral Interventional Devices (RAPID): Registry assessment of peripheral interventional devices core data elements." Journal of Vascular Surgery 67, no. 2 (February 2018): 637-644.e30.  Full Text
    • Jones, WS, Krucoff, MW, Morales, P, Wilgus, RW, Heath, AH, Williams, MF, Tcheng, JE, Marinac-Dabic, JD, Malone, ML, Reed, TL, Fukaya, R, Lookstein, R, Handa, N, Aronow, HD, Bertges, DJ, Jaff, MR, Tsai, TT, Smale, JA, Zaugg, MJ, Thatcher, RJ, Cronenwett, JL, Nc, D, Md, SS, Japan, T, Ny, NY, Ri, P, Vt, B, Mass, N, Colo, D, Ariz, T, Calif, SC, Minn, M, and Nh, L. "Registry Assessment of Peripheral Interventional Devices (RAPID)　- Registry Assessment of Peripheral Interventional Devices Core Data Elements." Circulation Journal : Official Journal of the Japanese Circulation Society 82, no. 2 (January 23, 2018): 316-322.  Full Text
    • O'Connor, CM, Psotka, MA, Fiuzat, M, Lindenfeld, J, Abraham, WT, Bristow, MR, Canos, D, Harrington, RA, Hillebrenner, M, Jessup, M, Malik, FI, Solomon, SD, Stockbridge, N, Tcheng, JE, Unger, EF, Whellan, DJ, Zuckerman, B, and Califf, RM. "Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory." Journal of the American College of Cardiology 71, no. 4 (January 2018): 443-453. (Review)  Full Text
    • Reed, TL, Drozda, JP, Baskin, KM, Tcheng, J, Conway, K, Wilson, N, Marinac-Dabic, D, Heise, T, and Krucoff, MW. "Advancing medical device innovation through collaboration and coordination of structured data capture pilots: Report from the Medical Device Epidemiology Network (MDEpiNet) Specific, Measurable, Achievable, Results-Oriented, Time Bound (SMART) Think Tank." Healthcare (Amsterdam, Netherlands) 5, no. 4 (December 2017): 158-164.  Full Text
    • Tcheng, JE. "RESPONSE: Enabling the Learning Health System, One FIT at a Time." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 70, no. 19 (November 1, 2017): 2454-2454.  Link to Item
    • Goyal, A, Gluckman, TJ, and Tcheng, JE. "What's in a Name? The New ICD-10 (10th Revision of the International Statistical Classification of Diseases and Related Health Problems) Codes and Type 2 Myocardial Infarction." Circulation 136, no. 13 (September 2017): 1180-1182.  Full Text
    • Boris, JR, Beland, MJ, Bergensen, LJ, Colan, SD, Dangel, J, Daniels, CJ, Davis, C, Everett, AD, Franklin, R, Gaynor, JW, Gray, DT, Hirsch-Romano, JC, Jacobs, JP, Jacobs, M, Jeffries, H, Krogmann, ON, Lomotan, EA, Lopez, L, Marelli, A, Martin, GR, Matherne, GP, Mavroudis, C, McCardle, K, Pearson, GD, Rosenthal, G, Scott, JS, Serwer, GA, Seslar, SS, Shaddy, R, Slesnick, T, Vener, DF, Walters, HL, Weinberg, PM, Bozkurt, B, Anderson, HV, Graham, GN, Jneid, H, Jones, GK, Kao, D, Kutcher, M, and Lopez, L et al. "2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards." CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES 10, no. 8 (August 1, 2017): 1-+. (Academic Article)  Link to Item
    • Boris, JR, Béland, MJ, Bergensen, LJ, Colan, SD, Dangel, J, Daniels, CJ, Davis, C, Everett, AD, Franklin, R, Gaynor, JW, Gray, DT, Hirsch-Romano, JC, Jacobs, JP, Jacobs, M, Jeffries, H, Krogmann, ON, Lomotan, EA, Lopez, L, Marelli, A, Martin, GR, Matherne, GP, Mavroudis, C, McCardle, K, Pearson, GD, Rosenthal, G, Scott, JS, Serwer, GA, Seslar, SS, Shaddy, R, Slesnick, T, Vener, DF, Walters, HL, and Weinberg, PM. "2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology." Journal of the American College of Cardiology 70, no. 8 (August 2017): 1029-1095.  Full Text
    • Doll, JA, Overton, R, Patel, MR, Rao, SV, Sketch, MH, Harrison, JK, and Tcheng, JE. "Morbidity and Mortality Conference for Percutaneous Coronary Intervention." Circulation. Cardiovascular quality and outcomes 10, no. 8 (August 2017).  Full Text
    • Maddox, TM, Albert, NM, Borden, WB, Curtis, LH, Ferguson, TB, Kao, DP, Marcus, GM, Peterson, ED, Redberg, R, Rumsfeld, JS, Shah, ND, Tcheng, JE, American Heart Association Council on Quality of Care and Outcomes Research, Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Functional Genomics and Translational Biology, and and Stroke Council, . "The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association." Circulation 135, no. 14 (April 2017): e826-e857. (Review)  Full Text
    • Baber, U, Giustino, G, Wang, T, Grines, C, McCoy, LA, Saha-Chaudhuri, P, Best, P, Skelding, KA, Ortega, R, Chieffo, A, Mehilli, J, Tcheng, J, and Mehran, R. "Comparisons of the uptake and in-hospital outcomes associated with second-generation drug-eluting stents between men and women: results from the CathPCI Registry." Coronary artery disease 27, no. 6 (September 2016): 442-448.  Full Text
    • Windle, JR, Katz, AS, Dow, JP, Fry, ETA, Keller, AM, Lamp, T, Lippitt, A, Paruche, MP, Resnic, FS, Serwer, GA, Slotwiner, DJ, Tcheng, JE, Tilkemeier, PL, Weiner, BH, and Weintraub, WS. "2016 ACC/ASE/ASNC/HRS/SCAI Health Policy Statement on Integrating the Healthcare Enterprise." Journal of the American College of Cardiology 68, no. 12 (September 2016): 1348-1364.  Full Text
    • Denardo, SJ, Vock, DM, Schmalfuss, CM, Young, GD, Tcheng, JE, and O'Connor, CM. "Baseline Hemodynamics and Response to Contrast Media During Diagnostic Cardiac Catheterization Predict Adverse Events in Heart Failure Patients." Circulation. Heart failure 9, no. 7 (July 2016).  Full Text
    • Hall, JL, Ryan, JJ, Bray, BE, Brown, C, Lanfear, D, Newby, LK, Relling, MV, Risch, NJ, Roden, DM, Shaw, SY, Tcheng, JE, Tenenbaum, J, Wang, TN, Weintraub, WS, American Heart Association Professional and Public Education and Publications Committee of the Council on Functional Genomics and Translational Biology, , Council on Clinical Cardiology, , Council on Epidemiology and Prevention, , Council on Quality of Care and Outcomes Research, and and Stroke Council, . "Merging Electronic Health Record Data and Genomics for Cardiovascular Research: A Science Advisory From the American Heart Association." Circulation. Cardiovascular Genetics 9, no. 2 (April 2016): 193-202.  Full Text
    • Zeitler, EP, Al-Khatib, SM, Drozda, JP, Kessler, LG, Kirtane, AJ, Kong, DF, Laschinger, J, Marinac-Dabic, D, Morice, M-C, Reed, T, Sedrakyan, A, Stein, KM, Tcheng, J, Krucoff, MW, and MDEpiNet, . "Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet)." American heart journal 171, no. 1 (January 2016): 64-72.e1-2-. (Review)  Full Text
    • Kansara, P, Weiss, S, Weintraub, WS, Hann, MC, Tcheng, J, Rab, ST, Klein, LW, and Interventional Council of the American College of Cardiology, . "Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?." JACC. Cardiovascular interventions 8, no. 13 (November 2015): 1647-1656.  Full Text
    • Hicks, KA, Tcheng, JE, Bozkurt, B, Chaitman, BR, Cutlip, DE, Farb, A, Fonarow, GC, Jacobs, JP, Jaff, MR, Lichtman, JH, Limacher, MC, Mahaffey, KW, Mehran, R, Nissen, SE, Smith, EE, Targum, SL, and ACC/AHA TASK FORCE ON CLINICAL DATA STANDARDS MEMBERS, . "2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 22, no. 5 (October 2015): 1041-1144.  Full Text
    • Hess, CN, Roe, MT, Clare, RM, Chiswell, K, Kelly, J, Tcheng, JE, Hagstrom, E, James, SK, Khouri, MG, Hirsch, BR, Kong, DF, Abernethy, AP, and Krucoff, MW. "Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention." Journal of the American Heart Association 4, no. 7 (July 6, 2015).  Full Text  Open Access Copy
    • Hicks, KA, Tcheng, JE, Bozkurt, B, Chaitman, BR, Cutlip, DE, Farb, A, Fonarow, GC, Jacobs, JP, Jaff, MR, Lichtman, JH, Limacher, MC, Mahaffey, KW, Mehran, R, Nissen, SE, Smith, EE, Targum, SL, American College of Cardiology, , and American Heart Association, . "2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)." Circulation 132, no. 4 (July 2015): 302-361.  Full Text
    • Hicks, KA, Tcheng, JE, Bozkurt, B, Chaitman, BR, Cutlip, DE, Farb, A, Fonarow, GC, Jacobs, JP, Jaff, MR, Lichtman, JH, Limacher, MC, Mahaffey, KW, Mehran, R, Nissen, SE, Smith, EE, and Targum, SL. "2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)." Journal of the American College of Cardiology 66, no. 4 (July 2015): 403-469.  Full Text
    • Sabol, ME, Finkle, J, Krucoff, M, Stockbridge, N, Parkhill, N, Shinagawa, K, Mahaffey, K, Tcheng, J, Lenihan, D, Melloni, C, Todaro, T, Michelson, E, Munley, J, Zander, J, and Oh, R. "Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms." Therapeutic Innovation & Regulatory Science 49, no. 4 (July 2015): 511-513.  Full Text
    • Patel, MR, Conte, MS, Cutlip, DE, Dib, N, Geraghty, P, Gray, W, Hiatt, WR, Ho, M, Ikeda, K, Ikeno, F, Jaff, MR, Jones, WS, Kawahara, M, Lookstein, RA, Mehran, R, Misra, S, Norgren, L, Olin, JW, Povsic, TJ, Rosenfield, K, Rundback, J, Shamoun, F, Tcheng, J, Tsai, TT, Suzuki, Y, Vranckx, P, Wiechmann, BN, White, CJ, Yokoi, H, and Krucoff, MW. "Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)." Journal of the American College of Cardiology 65, no. 9 (March 2015): 931-941.  Full Text
    • Sherwood, MW, and Tcheng, JE. "Eptifibatide in coronary intervention: past time for the next chapter." Circulation. Cardiovascular interventions 8, no. 2 (February 2015): e002340-.  Full Text
    • Hicks, KA, Tcheng, JE, Bozkurt, B, Chaitman, BR, Cutlip, DE, Farb, A, Fonarow, GC, Jacobs, JP, Jaff, MR, Lichtman, JH, Limacher, MC, Mahaffey, KW, Mehran, R, Nissen, SE, Smith, EE, and Targum, SL. "Erratum: 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards) (J Am Coll Cardiol 66 (403-469))." Journal of the American College of Cardiology 66, no. 8 (January 1, 2015).  Full Text
    • Patel, MR, Conte, MS, Cutlip, DE, Dib, N, Geraghty, P, Gray, W, Hiatt, WR, Ho, M, Ikeda, K, Ikeno, F, Jaff, MR, Jones, WS, Kawahara, M, Lookstein, RA, Mehran, R, Misra, S, Norgren, L, Olin, JW, Povsic, TJ, Rosenfield, K, Rundback, J, Shamoun, F, Tcheng, J, Tsai, TT, Suzuki, Y, Vranckx, P, Wiechmann, BN, White, CJ, Yokoi, H, and Krucoff, MW. "Erratum: Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from Peripheral Academic Research Consortium (PARC) (Journal of the American College of Cardiology (2015) 65:(931-41))." Journal of the American College of Cardiology 65, no. 23 (January 1, 2015): 2578-2579.  Full Text
    • Tcheng, JE, Crowley, J, Tomes, M, Reed, TL, Dudas, JM, Thompson, KP, Garratt, KN, Drozda, JP, and MDEpiNet UDI Demonstration Expert Workgroup, . "Unique device identifiers for coronary stent postmarket surveillance and research: a report from the Food and Drug Administration Medical Device Epidemiology Network Unique Device Identifier demonstration." American heart journal 168, no. 4 (October 2014): 405-413.e2. (Review)  Full Text
    • Ting, HH, Bates, ER, Beliveau, ME, Drozda, JP, Harold, JG, Krumholz, HM, Nishimura, RA, Oetgen, WJ, Sibley, JB, and Tcheng, JE. "Erratum: Update on the American Board of Internal Medicine Maintenance of Certification Program: A Report of the American College of Cardiologys Educational Quality Review Board (Journal of the American College of Cardiology (2014) 63 (92-100))." Journal of the American College of Cardiology 63, no. 25 PART A (July 1, 2014): 2887-2888.  Full Text
    • Ting, HH, Bates, ER, Beliveau, ME, Jr, DJP, Harold, JG, Krumholz, HM, Nishimura, RA, Oetgen, WJ, Sibley, JB, and Tcheng, JE. "Update on the American Board of Internal Medicine Maintenance of Certification Program: A Report of the American College of Cardiology's Educational Quality Review Board (vol 63, pg 92, 2014)." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 63, no. 25 (July 1, 2014): 2887-2888.  Full Text  Link to Item
    • Sanborn, TA, Tcheng, JE, Anderson, HV, Chambers, CE, Cheatham, SL, Decaro, MV, Durack, JC, Everett, AD, Gordon, JB, Hammond, WE, Hijazi, ZM, Kashyap, VS, Knudtson, M, Landzberg, MJ, Martinez-Rios, MA, Riggs, LA, Sim, KH, Slotwiner, DJ, Solomon, H, Szeto, WY, Weiner, BH, Weintraub, WS, and Windle, JR. "ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: A report of the american college of cardiology clinical quality committee." Circulation 129, no. 24 (June 17, 2014): 2578-2609. (Review)  Full Text
    • Hendel, RC, Bozkurt, B, Fonarow, GC, Jacobs, JP, Lichtman, JH, Smith, EE, Tcheng, JE, Wang, TY, and Weintraub, WS. "ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards." J Am Coll Cardiol 63, no. 21 (June 3, 2014): 2323-2334.  Full Text  Link to Item
    • Hendel, RC, Bozkurt, B, Fonarow, GC, Jacobs, JP, Lichtman, JH, Smith, EE, Tcheng, JE, Wang, TY, and Weintraub, WS. "ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards." Circulation 129, no. 22 (June 3, 2014): 2346-2357.  Full Text  Link to Item
    • Sanborn, TA, Tcheng, JE, Anderson, HV, Chambers, CE, Cheatham, SL, DeCaro, MV, Durack, JC, Everett, AD, Gordon, JB, Hammond, WE, Hijazi, ZM, Kashyap, VS, Knudtson, M, Landzberg, MJ, Martinez-Rios, MA, Riggs, LA, Sim, KH, Slotwiner, DJ, Solomon, H, Szeto, WY, Weiner, BH, Weintraub, WS, and Windle, JR. "ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee." Journal of the American College of Cardiology 63, no. 23 (June 2014): 2591-2623.  Full Text
    • Sanborn, TA, Tcheng, JE, Anderson, HV, Chambers, CE, Cheatham, SL, DeCaro, MV, Durack, JC, Everett, AD, Gordon, JB, Hammond, WE, Hijazi, ZM, Kashyap, VS, Knudtson, M, Landzberg, MJ, Martinez-Rios, MA, Riggs, LA, Sim, KH, Slotwiner, DJ, Solomon, H, Szeto, WY, Weiner, BH, Weintraub, WS, and Windle, JR. "ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee." Circulation 129, no. 24 (June 2014): 2578-2609.  Full Text
    • Ting, HH, Bates, ER, Beliveau, ME, Drozda, JP, Harold, JG, Krumholz, HM, Nishimura, RA, Oetgen, WJ, Sibley, JB, and Tcheng, JE. "Update on the American Board of Internal Medicine Maintenance of Certification Program: a report of the American College of Cardiology's Educational Quality Review Board." J Am Coll Cardiol 63, no. 1 (January 7, 2014): 92-100. (Review)  Full Text  Link to Item
    • Hendel, RC, Bozkurt, B, Fonarow, GC, Jacobs, JP, Lichtman, JH, Smith, EE, Tcheng, JE, Wang, TY, and Weintraub, WS. "ACC/AHA 2013 methodology for developing clinical data standards: A report of the american college of cardiology/American heart association task force on clinical data standards." Circulation 129, no. 22 (2014): 2346-2357.  Full Text
    • Denardo, SJ, Carpinone, PL, Vock, DM, Tcheng, JE, Phillips, HR, Willenberg, BJ, Batich, CD, and Pepine, CJ. "Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents." EuroIntervention 9, no. 3 (July 2013): 389-397.  Full Text  Link to Item
    • Cannon, CP, Brindis, RG, Chaitman, BR, Cohen, DJ, Cross, JT, Drozda, JP, Fesmire, FM, Fintel, DJ, Fonarow, GC, Fox, KA, Gray, DT, Harrington, RA, Hicks, KA, Hollander, JE, Krumholz, H, Labarthe, DR, Long, JB, Mascette, AM, Meyer, C, Peterson, ED, Radford, MJ, Roe, MT, Richmann, JB, Selker, HP, Shahian, DM, Shaw, RE, Sprenger, S, Swor, R, Underberg, JA, Van de Werf, F, Weiner, BH, and Weintraub, WS. "2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards)." Critical Pathways in Cardiology 12, no. 2 (June 2013): 65-105.  Full Text
    • Anderson, HV, Weintraub, WS, Radford, MJ, Kremers, MS, Roe, MT, Shaw, RE, Pinchotti, DM, and Tcheng, JE. "Standardized cardiovascular data for clinical research, registries, and patient care: a report from the Data Standards Workgroup of the National Cardiovascular Research Infrastructure project." J Am Coll Cardiol 61, no. 18 (May 7, 2013): 1835-1846. (Review)  Full Text  Link to Item
    • Cannon, CP, Brindis, RG, Chaitman, BR, Cohen, DJ, Cross, JT, Drozda, JP, Fesmire, FM, Fintel, DJ, Fonarow, GC, Fox, KA, Gray, DT, Harrington, RA, Hicks, KA, Hollander, JE, Krumholz, H, Labarthe, DR, Long, JB, Mascette, AM, Meyer, C, Peterson, ED, Radford, MJ, Roe, MT, Richmann, JB, Selker, HP, Shahian, DM, Shaw, RE, Sprenger, S, Swor, R, Underberg, JA, Van de Werf, F, Weiner, BH, and Weintraub, WS. "2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on clinical data standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards)." Journal of the American College of Cardiology 61, no. 9 (March 2013): 992-1025.  Full Text
    • Mehta, RH, Harjai, KJ, Boura, JA, Tcheng, JE, Dixon, SR, Stone, GW, and Grines, CL. "Short-term outcomes of balloon angioplasty versus stent placement for patients undergoing primary percutaneous coronary intervention: Implications for patients requiring early coronary artery bypass surgery." American Heart Journal (2013).  Full Text
    • Mehta, RH, Harjai, KJ, Boura, JA, Tcheng, JE, Dixon, SR, Stone, GW, and Grines, CL. "Interventional cardiology short-term outcomes of balloon angioplasty versus stent placement for patients undergoing primary percutaneous coronary intervention: Implications for patients requiring early coronary artery bypass surgery." American Heart Journal 165, no. 6 (2013): 1000-1007.  Full Text
    • Snyder, DC, Epps, S, Beresford, HF, Ennis, C, Levens, JS, Woody, SK, Tcheng, JE, Stacy, MA, and Nahm, M. "Research management team (RMT): a model for research support services at Duke University." Clin Transl Sci 5, no. 6 (December 2012): 464-469.  Full Text  Link to Item
    • Jolicoeur, EM, Sketch, MJ, Patel, MR, and Tcheng, JE. "Rebuttal: the CTO "no-controversy" controversy: should the field of CTO-PCI be allowed to expand?." Catheter Cardiovasc Interv 80, no. 1 (July 1, 2012): 154-155. (Letter)  Full Text  Link to Item
    • Murphy, SN, Dubey, A, Embi, PJ, Harris, PA, Richter, BG, Turisco, F, Weber, GM, Tcheng, JE, and Keogh, D. "Current state of information technologies for the clinical research enterprise across academic medical centers." Clinical and Translational Science 5, no. 3 (June 2012): 281-284.  Full Text
    • Tcheng, JE, and Mackay, SM. "Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients." Am J Cardiovasc Drugs 12, no. 2 (April 1, 2012): 83-91. (Review)  Full Text  Link to Item
    • Mehta, RH, Yu, J, Piccini, JP, Tcheng, JE, Farkouh, ME, Reiffel, J, Fahy, M, Mehran, R, and Stone, GW. "Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial)." Am J Cardiol 109, no. 6 (March 15, 2012): 805-812.  Full Text  Link to Item
    • Jolicœur, EM, Sketch, MJ, Wojdyla, DM, Javaheri, SP, Nosib, S, Lokhnygina, Y, Patel, MR, Shaw, LK, and Tcheng, JE. "Percutaneous coronary interventions and cardiovascular outcomes for patients with chronic total occlusions." Catheter Cardiovasc Interv 79, no. 4 (March 1, 2012): 603-612.  Full Text  Link to Item
    • Hendel, RC, Bozkurt, B, Fonarow, GC, Jacobs, JP, Peterson, PN, Roger, VL, Smith, EE, Tcheng, JE, Wang, T, Weintraub, WS, and Clinical, ACCFAHATF. "2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS Key Data Elements and Definitions for Peripheral Atherosclerotic Vascular Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease)." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 59, no. 3 (January 17, 2012): 294-357.  Full Text  Link to Item
    • Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease, , Creager, MA, Belkin, M, Bluth, EI, Casey, DE, Chaturvedi, S, Dake, MD, Fleg, JL, Hirsch, AT, Jaff, MR, Kern, JA, Malenka, DJ, Martin, ET, Mohler, ER, Murphy, T, Olin, JW, Regensteiner, JG, Rosenwasser, RH, Sheehan, P, Stewart, KJ, Treat-Jacobson, D, Upchurch, GR, White, CJ, Ziffer, JA, Hendel, RC, Bozkurt, B, Fonarow, GC, Jacobs, JP, Peterson, PN, Roger, VL, Smith, EE, Tcheng, JE, and Wang, T et al. "2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease)." Circulation 125, no. 2 (January 17, 2012): 395-467.  Full Text  Link to Item
    • Tcheng, JE, and Mackay, SM. "Prasugrel versus Clopidogrel Antiplatelet Therapy after Acute Coronary Syndrome." AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS 12, no. 2 (2012): 83-91.  Full Text  Link to Item
    • Denardo, SJ, Vock, DM, Schmalfuss, CM, Young, GD, Tcheng, JE, Echols, MR, Pieper, KS, and O'Connor, CM. "Baseline Hemodynamics with Cardiac Performance Response to Contrast Media During Diagnostic Cardiac Catheterization Enhances Prediction of Adverse Events in Heart Failure Patients." CIRCULATION 124, no. 21 (November 22, 2011).  Link to Item
    • Weintraub, WS, Karlsberg, RP, Tcheng, JE, Boris, JR, Buxton, AE, Dove, JT, Fonarow, GC, Goldberg, LR, Heidenreich, P, Hendel, RC, Jacobs, AK, Lewis, W, Mirro, MJ, Shahian, DM, Hendel, RC, Bozkurt, B, Jacobs, JP, Peterson, PN, Roger, VL, Smith, EE, Tcheng, JE, Wang, T, American College of Cardiology Foundation, , and American Heart Association Task Force on Clinical Data Standards, . "ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards." Circulation 124, no. 1 (July 5, 2011): 103-123.  Full Text  Link to Item
    • Weintraub, WS, Karlsberg, RP, Tcheng, JE, Boris, JR, Buxton, AE, Dove, JT, Fonarow, GC, Goldberg, LR, Heidenreich, P, Hendel, RC, Jacobs, AK, Lewis, W, Mirro, MJ, and Shahian, DM. "ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards." J Am Coll Cardiol 58, no. 2 (July 5, 2011): 202-222.  Full Text  Link to Item
    • Segall, N, Saville, JG, L'Engle, P, Carlson, B, Wright, MC, Schulman, K, and Tcheng, JE. "Usability evaluation of a personal health record." AMIA Annu Symp Proc 2011 (2011): 1233-1242.  Link to Item
    • Walden, A, Nahm, M, Barnett, ME, Conde, JG, Dent, A, Fadiel, A, Perry, T, Tolk, C, Tcheng, JE, and Eisenstein, EL. "Economic analysis of centralized vs. decentralized electronic data capture in multi-center clinical studies." Stud Health Technol Inform 164 (2011): 82-88.  Link to Item
    • Sorajja, P, Gersh, BJ, Cox, DA, McLaughlin, MG, Zimetbaum, P, Costantini, C, Stuckey, T, Tcheng, JE, Mehran, R, Lansky, AJ, Grines, CL, and Stone, GW. "Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial." J Am Coll Cardiol 55, no. 14 (April 6, 2010): 1416-1424.  Full Text  Link to Item
    • Deibele, AJ, Jennings, LK, Tcheng, JE, Neva, C, Earhart, AD, and Gibson, CM. "Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (ICE) Trial." Circulation 121, no. 6 (February 16, 2010): 784-791.  Full Text  Link to Item
    • Kruk, M, Buller, CE, Tcheng, JE, Dzavík, V, Menon, V, Mancini, GBJ, Forman, SA, Kurray, P, Busz-Papiez, B, Lamas, GA, and Hochman, JS. "Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT])." Am J Cardiol 105, no. 1 (January 1, 2010): 10-16.  Full Text  Link to Item
    • Tcheng, JE, and Zidar, DA. "Gone but not forgotten: the case for drug-eluting stents in percutaneous revascularization of the chronic coronary total occlusion." JACC Cardiovasc Interv 2, no. 12 (December 2009): 1266-1268.  Full Text  Link to Item
    • Guerra, DR, and Tcheng, JE. "Prasugrel: Clinical development and therapeutic application." Adv Ther 26, no. 11 (November 2009): 999-1011. (Review)  Full Text  Link to Item
    • Madan, M, Nikhil, J, Hellkamp, AS, Pieper, KS, Labinaz, M, Cohen, EA, Buller, CE, Cantor, WJ, Seidelin, P, Ducas, J, Carere, RG, Natarajan, MK, O'Shea, JC, Tcheng, JE, and ESPRIT Investigators, . "Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study." Can J Cardiol 25, no. 8 (August 2009): e269-e272.  Link to Item
    • Rabbani, LE, Iyengar, S, Dangas, GD, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Stant, J, Fahy, M, Lansky, AJ, Mehran, R, and Stone, GW. "Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction." J Interv Cardiol 22, no. 4 (August 2009): 378-384.  Full Text  Link to Item
    • Nikolsky, E, Mehran, R, Sadeghi, HM, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Fahy, M, Lansky, AJ, and Stone, GW. "Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial." JACC Cardiovasc Interv 2, no. 7 (July 2009): 624-632.  Full Text  Link to Item
    • Denardo, SJ, Hassan, MHM, Schofield, RS, Hill, JA, Davis, KE, and Tcheng, JE. "Percutaneous Coronary Intervention for Treatment of Symptomatic Ischemic Heart Failure With Normal Left Ventricular Systolic Function." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 53, no. 10 (March 10, 2009): A51-A51.  Link to Item
    • Tcheng, JE, Lim, IH, Srinivasan, S, Jozic, J, Gibson, CM, O'Shea, JC, Puma, JA, and Simon, DI. "Stent parameters predict major adverse clinical events and the response to platelet glycoprotein IIb/IIIa blockade: findings of the ESPRIT trial." Circ Cardiovasc Interv 2, no. 1 (February 2009): 43-51.  Full Text  Link to Item
    • Lansky, AJ, Tsuchiya, Y, Brener, M, Mehran, R, Cristea, E, Pietras, C, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Guagliumi, G, Stuckey, T, Turco, M, Carroll, JD, Rutherford, BD, Leon, MB, Moses, J, and Stone, GW. "Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial." Catheter Cardiovasc Interv 72, no. 7 (December 1, 2008): 917-924.  Full Text  Link to Item
    • Kruk, M, Buller, CE, Dzavik, V, Mancini, GBJ, Kurray, P, Tcheng, JE, Menon, V, Forman, SA, Lamas, GA, Hochman, JS, and Investigators, OAT. "Late recanalization of infarct related artery has no impact on clinical outcomes regardless of ejection fraction: Results from the Occluded Artery Trial (OAT)." EUROPEAN HEART JOURNAL 29 (September 2008): 679-679.  Link to Item
    • Casterella, PJ, and Tcheng, JE. "Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular Interventions guidelines for adjunctive pharmacologic therapy during percutaneous coronary interventions: practical implications, new clinical data, and recommended guideline revisions." Am Heart J 155, no. 5 (May 2008): 781-790. (Review)  Full Text  Link to Item
    • Novaro, GM, Asher, CR, Bhatt, DL, Moliterno, DJ, Harrington, RA, Lincoff, AM, Newby, LK, Tcheng, JE, Hsu, AP, and Pinski, SL. "Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites." Am J Cardiol 101, no. 4 (February 15, 2008): 506-509.  Full Text  Link to Item
    • Denardo, SJ, Davis, KE, and Tcheng, JE. "Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention." Am J Cardiol 100, no. 9 (November 1, 2007): 1376-1382.  Full Text  Link to Item
    • Dery, J, Griffin, J, Pieper, KS, Harrington, RA, and Tcheng, JE. "Comparison of outcomes between patients undergoing percutaneous coronary stent implantation with eptifibatide and abciximab: An analysis using propensity score methods." CANADIAN JOURNAL OF CARDIOLOGY 23 (October 2007): 59C-59C.  Link to Item
    • Dery, JP, Griffin, J, Pieper, KS, Harrington, RA, and Tcheng, JE. "Comparison of outcomes between patients undergoing percutaneous coronary stent implantation with eptifibatide and abciximab: an analysis using propensity score methods." EUROPEAN HEART JOURNAL 28 (September 2007): 184-184.  Link to Item
    • Dery, J-P, Campbell, ME, Mathias, J, Pieper, KS, Harrington, RA, Madan, M, Gibson, CM, Tolleson, TR, O'Shea, JC, Tcheng, JE, and ESPRIT Investigators, . "Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trial." Catheter Cardiovasc Interv 70, no. 1 (July 1, 2007): 43-50.  Full Text  Link to Item
    • Sorajja, P, Gersh, BJ, Cox, DA, McLaughlin, MG, Zimetbaum, P, Costantini, C, Stuckey, T, Tcheng, JE, Mehran, R, Lansky, AJ, Grines, CL, and Stone, GW. "Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction." European Heart Journal 28, no. 14 (July 2007): 1709-1716.  Full Text
    • Prasad, A, Stone, GW, Stuckey, TD, Costantini, CO, Mehran, R, Garcia, E, Tcheng, JE, Cox, DA, Grines, CL, Lansky, AJ, and Gersh, BJ. "Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty." Am J Cardiol 99, no. 8 (April 15, 2007): 1067-1071.  Full Text  Link to Item
    • Nikolsky, E, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Sadeghi, M, Mehran, R, Lansky, AJ, Na, Y, and Stone, GW. "Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)." The American Journal of Cardiology 99, no. 8 (April 2007): 1055-1061.  Full Text
    • Radford, MJ, Heidenreich, PA, Bailey, SR, Goff, DC, Grover, FL, Havranek, EP, Kuntz, RE, Malenka, DJ, Peterson, ED, Redberg, RF, Roger, VL, Cardiology, ACO, and Standards, AHATFOCD. "ACC/AHA 2007 methodology for the development of clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards." Journal of the American College of Cardiology 49, no. 7 (February 2007): 830-837. (Academic Article)
    • Harjai, KJ, Stone, GW, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Na, Y, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Rutherford, BD, Lansky, AJ, and Mehran, R. "Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitors." Am J Cardiol 99, no. 2 (January 15, 2007): 202-207.  Full Text  Link to Item
    • Berger, JS, Petersen, JL, Tcheng, JE, and Phillips, HR. "Clinical implications of vulnerable plaque." Future Cardiol 2, no. 6 (November 2006): 721-731.  Full Text  Link to Item
    • Saw, J, Bhatt, DL, Moliterno, DJ, Brener, SJ, Steinhubl, SR, Lincoff, AM, Tcheng, JE, Harrington, RA, Simoons, M, Hu, T, Sheikh, MA, Kereiakes, DJ, and Topol, EJ. "The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials." J Am Coll Cardiol 48, no. 8 (October 17, 2006): 1567-1572.  Full Text  Link to Item
    • Tcheng, JE, and Kinney, KG. "After fibrinolysis: is cardiac catheterization the answer?." J Am Coll Cardiol 48, no. 7 (October 3, 2006): 1336-1338.  Full Text  Link to Item
    • Tcheng, JE. "Debate of adjunctive pharmacology for percutaneous coronary intervention: anticoagulation and clopidogrel are not (always) enough." J Interv Cardiol 19, no. 5 (October 2006): 456-463. (Review)  Full Text  Link to Item
    • Cox, DA, Stone, GW, Grines, CL, Stuckey, T, Zimetbaum, PJ, Tcheng, JE, Turco, M, Garcia, E, Guagliumi, G, Iwaoka, RS, Mehran, R, O'Neill, WW, Lansky, AJ, Griffin, JJ, and CADILLAC Investigators, . "Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial)." Am J Cardiol 98, no. 3 (August 1, 2006): 331-337.  Full Text  Link to Item
    • Deibele, AJ, Kirtane, AJ, Pinto, DS, Lucca, MJ, Neva, C, Shui, A, Murphy, SA, Tcheng, JE, and Gibson, CM. "Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina." J Thromb Thrombolysis 22, no. 1 (August 2006): 47-50.  Full Text  Link to Item
    • Brodie, BR, Stone, GW, Cox, DA, Stuckey, TD, Turco, M, Tcheng, JE, Berger, P, Mehran, R, McLaughlin, M, Costantini, C, Lansky, AJ, and Grines, CL. "Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial." American Heart Journal 151, no. 6 (June 2006): 1231-1238.  Full Text
    • Kandzari, DE, Tcheng, JE, Gersh, BJ, Cox, DA, Stuckey, T, Turco, M, Mehran, R, Garcia, E, Zimetbaum, P, McGlaughlin, MG, Lansky, AJ, Costantini, CO, Grines, CL, Stone, GW, and CADILLAC Investigators, . "Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction." American Heart Journal 151, no. 6 (June 2006): 1288-1295.  Full Text
    • Halkin, A, Stone, GW, Grines, CL, Cox, DA, Rutherford, BD, Esente, P, Meils, CM, Albertsson, P, Farah, A, Tcheng, JE, Lansky, AJ, and Mehran, R. "Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction." J Am Coll Cardiol 47, no. 5 (March 7, 2006): 951-961.  Full Text  Link to Item
    • Puma, JA, Banko, LT, Pieper, KS, Sacchi, TJ, O'Shea, JC, Dery, JP, and Tcheng, JE. "Clinical characteristics predict benefits from eptifibatide therapy during coronary stenting: insights from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy (ESPRIT) trial." J Am Coll Cardiol 47, no. 4 (February 21, 2006): 715-718.  Full Text  Link to Item
    • De Luca, G, Suryapranata, H, Stone, GW, Antoniucci, D, Tcheng, JE, Neumann, F-J, Bonizzoni, E, Topol, EJ, and Chiariello, M. "Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials." J Am Coll Cardiol 47, no. 3 (February 7, 2006): 685-686. (Letter)  Full Text  Link to Item
    • Musser, RC, and Tcheng, JE. "Quantitative and qualitative comparison of text-based and graphical user interfaces for Computerized Provider Order Entry." AMIA Annu Symp Proc (2006): 1041-.  Link to Item
    • Nikolsky, E, Stone, GW, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Negoita, M, Lansky, AJ, and Mehran, R. "Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction." American Heart Journal 151, no. 1 (January 2006): 168-175.  Full Text
    • Vikoren, TH, Musser, RC, Tcheng, JE, and Nunley, JA. "From clinical pathways to CPOE: challenges and opportunities in standardization and computerization of postoperative orders for total joint replacement." J Surg Orthop Adv 15, no. 4 (2006): 195-200.  Link to Item
    • Halkin, A, Stone, GW, Grines, CL, Cox, DA, Stuckey, TD, Garcia, E, Guagliumi, G, Mehran, R, Rutherford, BD, Griffin, JJ, Na, Y, Tcheng, JE, and Turco, M. "Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC registry)." Am J Cardiol 96, no. 12 (December 15, 2005): 1649-1655.  Full Text  Link to Item
    • Nikolsky, E, Sadeghi, HM, Effron, MB, Mehran, R, Lansky, AJ, Na, Y, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Stuckey, TD, Turco, M, Carroll, JD, Grines, CL, and Stone, GW. "Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction." Am J Cardiol 96, no. 4 (August 15, 2005): 474-481.  Full Text  Link to Item
    • Halkin, A, Stone, GW, Dixon, SR, Grines, CL, Tcheng, JE, Cox, DA, Garcia, E, Brodie, B, Stuckey, TD, Mehran, R, and Lansky, AJ. "Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction." The American Journal of Cardiology 96, no. 3 (August 2005): 325-331.  Full Text
    • Weisz, G, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, TD, Rutherford, BD, Mehran, R, Aymong, E, Lansky, A, Grines, CL, and Stone, GW. "Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited." American Heart Journal 150, no. 2 (August 2005): 358-364.  Full Text
    • Cantor, WJ, Madan, M, O'Shea, JC, Chisholm, RJ, Lui, HK, Cohen, DJ, Feldman, RL, Green, R, Hellkamp, AS, Kitt, MM, and Tcheng, JE. "Bailout use of platelet glycoprotein IIb-IIIa inhibition during coronary stent implantation: observations from the ESPRIT trial." J Invasive Cardiol 17, no. 7 (July 2005): 360-364.  Link to Item
    • Halkin, A, Singh, M, Nikolsky, E, Grines, CL, Tcheng, JE, Garcia, E, Cox, DA, Turco, M, Stuckey, TD, Na, Y, Lansky, AJ, Gersh, BJ, O'Neill, WW, Mehran, R, and Stone, GW. "Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score." Journal of the American College of Cardiology 45, no. 9 (May 2005): 1397-1405.  Full Text
    • Paraschos, A, Callwood, D, Wightman, MB, Tcheng, JE, Phillips, HR, Stiles, GL, Daniel, JM, and Sketch, MH. "Outcomes following elective percutaneous coronary intervention without on-site surgical backup in a community hospital." Am J Cardiol 95, no. 9 (May 1, 2005): 1091-1093.  Full Text  Link to Item
    • Lansky, AJ, Pietras, C, Costa, RA, Tsuchiya, Y, Brodie, BR, Cox, DA, Aymong, ED, Stuckey, TD, Garcia, E, Tcheng, JE, Mehran, R, Negoita, M, Fahy, M, Cristea, E, Turco, M, Leon, MB, Grines, CL, and Stone, GW. "Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial." Circulation 111, no. 13 (April 5, 2005): 1611-1618.  Full Text  Link to Item
    • De Luca, G, Suryapranata, H, Stone, GW, Antoniucci, D, Tcheng, JE, Neumann, F-J, Van de Werf, F, Antman, EM, and Topol, EJ. "Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials." Jama 293, no. 14 (April 2005): 1759-1765.  Full Text
    • Sorajja, P, Gersh, BJ, Costantini, C, McLaughlin, MG, Zimetbaum, P, Cox, DA, Garcia, E, Tcheng, JE, Mehran, R, Lansky, AJ, Kandzari, DE, Grines, CL, and Stone, GW. "Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction." European Heart Journal 26, no. 7 (April 2005): 667-674.  Full Text
    • Exaire, JE, Tcheng, JE, Kereiakes, DJ, Kleiman, NS, Applegate, RJ, Moliterno, DJ, and ELECT Investigators, . "Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel." Catheter Cardiovasc Interv 64, no. 3 (March 2005): 369-372.  Full Text  Link to Item
    • Prasad, A, Stone, GW, Stuckey, TD, Costantini, CO, Zimetbaum, PJ, McLaughlin, M, Mehran, R, Garcia, E, Tcheng, JE, Cox, DA, Grines, CL, Lansky, AJ, and Gersh, BJ. "Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction." Journal of the American College of Cardiology 45, no. 4 (February 2005): 508-514.  Full Text
    • Tcheng, JE, and Kindsvater, S. "Hospital percutaneous coronary intervention volume and outcome: does it matter?." J Interv Cardiol 18, no. 1 (February 2005): 17-19.  Full Text  Link to Item
    • Denardo, SJ, Davis, KE, and Tcheng, JE. "Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy." Am Heart J 149, no. 1 (January 2005): 138-144.  Full Text  Link to Item
    • Stuckey, TD, Stone, GW, Cox, DA, Tcheng, JE, Garcia, E, Carroll, J, Guagliumi, G, Rutherford, BD, Griffin, JJ, Turco, M, Lansky, AJ, Mehran, R, Fahy, M, Brodie, BR, Grines, CL, and CADILLAC investigators, . "Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial)." Am J Cardiol 95, no. 1 (January 1, 2005): 1-7.  Full Text  Link to Item
    • Stuckey, TD, Stone, GW, Cox, DA, Tcheng, JE, Garcia, E, Carroll, J, Guagliumi, G, Rutherford, BD, Griffin, JJ, Turco, M, Lansky, AJ, Mehran, R, Fahy, M, Brodie, BR, Grines, CL, and Investigators, CADILLAC. "Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary Angioplasty in acute myocardial infarction (the CADILLAC trial)." AMERICAN JOURNAL OF CARDIOLOGY 95, no. 1 (January 1, 2005): 1-7.  Full Text  Link to Item
    • Tcheng, J, Mann, H, London, AJ, and Mann, J. "Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): A critical appraisal. Comment." Clinical Trials 2, no. 3 (2005): 242-243.
    • Halabi, AR, Sketch, MH, Tcheng, JE, Goel, P, Aggarwal, K, Ramsdale, D, Aziz, S, Sangha, RS, and Hui, PYM. "Which is the true channel?." The Journal of Invasive Cardiology 16, no. 12 (December 2004): 716-718.
    • Madan, M, Labinaz, M, Cohen, EA, Buller, CE, Cantor, WJ, Seidelin, P, Ducas, J, Carere, RG, Natarajan, MK, Pieper, KS, Hafley, GE, O'Shea, JC, Kitt, MM, Califf, RM, Tcheng, JE, and ESPRIT Investigators, . "A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting." The Canadian Journal of Cardiology 20, no. 13 (November 2004): 1343-1349.
    • Dangas, G, Aymong, ED, Mehran, R, Tcheng, JE, Grines, CL, Cox, DA, Garcia, E, Griffin, JJ, Guagliumi, G, Stuckey, T, Lansky, AJ, Stone, GW, and CADILLAC Investigators, . "Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)." Am J Cardiol 94, no. 8 (October 15, 2004): 983-988.  Full Text  Link to Item
    • Kandzari, DE, Tcheng, JE, Grines, CL, Cox, DA, Stuckey, T, Griffin, JJ, Turco, M, Garcia, E, Carroll, JD, Fahy, M, Lansky, AJ, Mehran, R, Stone, GW, and CADILLAC Investigators, . "Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction." Am J Cardiol 94, no. 8 (October 15, 2004): 1029-1033.  Full Text  Link to Item
    • Rebeiz, AG, Dery, J-P, Tsiatis, AA, O'shea, JC, Johnson, BA, Hellkamp, AS, Pieper, KS, Gilchrist, IC, Slater, J, Muhlestein, JB, Joseph, D, Kitt, MM, Tcheng, JE, and ESPRIT substudy, . "Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy)." Am J Cardiol 94, no. 7 (October 1, 2004): 926-929.  Full Text  Link to Item
    • McLaughlin, MG, Stone, GW, Aymong, E, Gardner, G, Mehran, R, Lansky, AJ, Grines, CL, Tcheng, JE, Cox, DA, Stuckey, T, Garcia, E, Guagliumi, G, Turco, M, Josephson, ME, Zimetbaum, P, and Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications trial, . "Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial." J Am Coll Cardiol 44, no. 6 (September 15, 2004): 1215-1223.  Full Text  Link to Item
    • Guagliumi, G, Stone, GW, Cox, DA, Stuckey, T, Tcheng, JE, Turco, M, Musumeci, G, Griffin, JJ, Lansky, AJ, Mehran, R, Grines, CL, and Garcia, E. "Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial." Circulation 110, no. 12 (September 7, 2004): 1598-1604.  Full Text
    • Cantor, WJ, Tcheng, JE, Blankenship, JC, O'Shea, JC, Pieper, KS, Criger, DA, Madan, M, Ducas, J, Sheldon, WS, Tannenbaum, MA, Smith, JE, Kitt, MM, and Gilchrist, IC. "Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experience." J Invasive Cardiol 16, no. 9 (September 2004): 475-481.  Link to Item
    • Sadeghi, HM, Grines, CL, Chandra, HR, Mehran, R, Fahy, M, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Stuckey, TD, Lansky, AJ, O'Neill, WW, and Stone, GW. "Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial)." Am J Cardiol 94, no. 5 (September 1, 2004): 637-A9.  Full Text  Link to Item
    • Nikolsky, E, Aymong, ED, Halkin, A, Grines, CL, Cox, DA, Garcia, E, Mehran, R, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Cohen, DA, Negoita, M, Lansky, AJ, and Stone, GW. "Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial." J Am Coll Cardiol 44, no. 3 (August 4, 2004): 547-553.  Full Text  Link to Item
    • Costantini, CO, Stone, GW, Mehran, R, Aymong, E, Grines, CL, Cox, DA, Stuckey, T, Turco, M, Gersh, BJ, Tcheng, JE, Garcia, E, Griffin, JJ, Guagliumi, G, Leon, MB, and Lansky, AJ. "Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction." J Am Coll Cardiol 44, no. 2 (July 21, 2004): 305-312.  Full Text  Link to Item
    • Costantini, CO, Stone, GW, Mehran, R, Aymong, E, Grines, CL, Cox, DA, Stuckey, T, Turco, M, Gersh, BJ, Tcheng, JE, Garcia, E, Griffin, JJ, Guagliumi, G, Leon, MB, and Lansky, AJ. "Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 44, no. 2 (July 21, 2004): 305-312.  Full Text  Link to Item
    • Rajagopal, V, Gurm, HS, Bhatt, DL, Lincoff, AM, Tcheng, JE, Kereiakes, DJ, Kleiman, NS, Jia, G, and Topol, EJ. "Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality." Am J Cardiol 94, no. 2 (July 15, 2004): 190-192.  Full Text  Link to Item
    • Gurm, HS, Lincoff, AM, Kleiman, NS, Kereiakes, DJ, Tcheng, JE, Aronow, HD, Askari, AT, Brennan, DM, and Topol, EJ. "Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions." Am J Cardiol 94, no. 1 (July 1, 2004): 30-34.  Full Text  Link to Item
    • Halkin, A, Grines, CL, Cox, DA, Garcia, E, Mehran, R, Tcheng, JE, Griffin, JJ, Guagliumi, G, Brodie, B, Turco, M, Rutherford, BD, Aymong, E, Lansky, AJ, and Stone, GW. "Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction." Journal of the American College of Cardiology 43, no. 10 (May 2004): 1780-1787.  Full Text
    • Pellizzon, GG, Grines, CL, Cox, DA, Stuckey, T, Tcheng, JE, Garcia, E, Guagliumi, G, Turco, M, Lansky, AJ, Griffin, JJ, Cohen, DJ, Aymong, E, Mehran, R, O'Neill, WW, and Stone, GW. "Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial." J Am Coll Cardiol 43, no. 8 (April 21, 2004): 1368-1374.  Full Text  Link to Item
    • Dery, J-P, Braden, GA, Lincoff, AM, Kereiakes, DJ, Browne, K, Little, T, George, BS, Sane, DC, Cines, DB, Effron, MB, Mascelli, MA, Langrall, MA, Damaraju, L, Barnathan, ES, Tcheng, JE, and ReoPro Readministration Registry Investigators, . "Final results of the ReoPro readministration registry." Am J Cardiol 93, no. 8 (April 15, 2004): 979-984.  Full Text  Link to Item
    • Tcheng, JE. "For how long should treatment with clopidogrel be continued after coronary stent implantation? Reply." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 43, no. 7 (April 7, 2004): 1331-1332.  Full Text  Link to Item
    • Konstance, R, Tcheng, JE, Wightman, MB, Kelly, LP, Moore, A, Harrison, JK, and Sketch, MH. "Incidence and predictors of major vascular complications after percutaneous coronary intervention in the glycoprotein IIb/IIIa platelet inhibitor era." Journal of Interventional Cardiology 17, no. 2 (April 2004): 65-70.  Full Text
    • Prasad, A, Stone, GW, Aymong, E, Zimetbaum, PJ, McLaughlin, M, Mehran, R, Garcia, E, Tcheng, JE, Cox, DA, Grines, CL, Gersh, BJ, and CADILLAC trial, . "Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial." American Heart Journal 147, no. 4 (April 2004): 669-675.  Full Text
    • Kandzari, DE, Hasselblad, V, Tcheng, JE, Stone, GW, Califf, RM, Kastrati, A, Neumann, F-J, Brener, SJ, Montalescot, G, Kong, DF, and Harrington, RA. "Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials." American Heart Journal 147, no. 3 (March 2004): 457-462. (Review)  Full Text
    • Halkin, A, Aymong, E, Cox, DA, Mehran, R, Lansky, AJ, Fahy, M, Weisz, G, Garcia, E, Tcheng, JE, Grines, CL, and Stone, GW. "Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial)." Am J Cardiol 93, no. 3 (February 1, 2004): 349-353.  Full Text  Link to Item
    • Antoniucci, D, Rodriguez, A, Hempel, A, and Tcheng, JE. "Trial finds adding abciximab to stent reperfusion improves survival in acute myocardial infarction." Evidence-based Cardiovascular Medicine 8, no. 2 (2004): 147-150.  Full Text
    • Dery, JP, Harrington, RA, and Tcheng, JE. "GP IIb/IIIa blockade in elective percutaneous coronary intervention." Curr Pharm Des 10, no. 4 (2004): 387-398. (Review)  Link to Item
    • McLellan, CS, O'Shea, JC, Tcheng, JE, and Labinaz, M. "Coronary artery stenting and eptifibatide treatment in diabetes." Cardiology Review 21, no. 4 (2004): 18+20-23+30.
    • Rozenman, Y, and Tcheng, JE. "For how long should treatment with clopidogrel be continued after coronary stent implantation? [1] (multiple letters)." Journal of the American College of Cardiology 43, no. 7 (2004): 1331-1332.  Full Text
    • Bakhai, A, Stone, GW, Grines, CL, Murphy, SA, Githiora, L, Berezin, RH, Cox, DA, Stuckey, T, Griffin, JJ, Tcheng, JE, Cohen, DJ, and CADILLAC Investigators, . "Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial." Circulation 108, no. 23 (December 9, 2003): 2857-2863.  Full Text  Link to Item
    • Bakhai, A, Stone, GW, Grines, CL, Murphy, SA, Githiora, L, Berezin, RH, Cox, DA, Stuckey, T, Griffin, JJ, Tcheng, JE, Cohen, DJ, and Investigators, CADILLAC. "Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction - Results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial." CIRCULATION 108, no. 23 (December 9, 2003): 2857-2863.  Full Text  Link to Item
    • Sadeghi, HM, Stone, GW, Grines, CL, Mehran, R, Dixon, SR, Lansky, AJ, Fahy, M, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Stuckey, TD, Turco, M, and Carroll, JD. "Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction." Circulation 108, no. 22 (December 2, 2003): 2769-2775.  Full Text  Link to Item
    • Ashby, DT, Aymong, EA, Grines, CL, Cox, DA, Garcia, E, Mehran, R, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Carroll, JD, Turco, M, Lansky, AJ, Stone, GW, and CADILLAC trial, . "Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial)." Am J Cardiol 92, no. 9 (November 1, 2003): 1095-1098.  Link to Item
    • Ashby, DT, Aymong, EA, Tcheng, JE, Grines, CL, Cox, DA, Mehran, R, Garcia, E, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Lansky, AJ, Stone, GW, and CADILLAC Trial, . "Outcomes following bail-out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial)." Am J Cardiol 92, no. 9 (November 1, 2003): 1091-1094.  Link to Item
    • Gurm, HS, Bhatt, DL, Lincoff, AM, Tcheng, JE, Kereiakes, DJ, Kleiman, NS, Jia, G, and Topol, EJ. "Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials." Heart (British Cardiac Society) 89, no. 10 (October 2003): 1200-1204.  Full Text
    • Kandzari, DE, Tcheng, JE, Cohen, DJ, Bakhai, A, Grines, CL, Cox, DA, Effron, M, Stuckey, T, Griffin, JJ, Turco, M, Carroll, JD, Fahy, M, Mehran, R, Stone, GW, and CADILLAC Investigators, . "Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial)." Am J Cardiol 92, no. 7 (October 1, 2003): 779-784.  Link to Item
    • Tcheng, JE, and Campbell, ME. "Platelet inhibition strategies in percutaneous coronary intervention: competition or coopetition?." J Am Coll Cardiol 42, no. 7 (October 1, 2003): 1196-1198.  Link to Item
    • Cox, DA, Stone, GW, Grines, CL, Stuckey, T, Cohen, DJ, Tcheng, JE, Garcia, E, Guagliumi, G, Iwaoka, RS, Fahy, M, Turco, M, Lansky, AJ, Griffin, JJ, Mehran, R, and CADILLAC Investigators, . "Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial." J Am Coll Cardiol 42, no. 6 (September 17, 2003): 971-977.  Link to Item
    • Moliterno, DJ, Hermiller, JB, Kereiakes, DJ, Yow, E, Applegate, RJ, Braden, GA, Dippel, EJ, Furman, MI, Grines, CL, Kleiman, NS, Levine, GN, Mann, T, Nair, RN, Stine, RA, Yacubov, SJ, Tcheng, JE, and ELECT Investigators, . "A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study." J Am Coll Cardiol 42, no. 6 (September 17, 2003): 1132-1139.  Link to Item
    • Tcheng, JE, Kandzari, DE, Grines, CL, Cox, DA, Effron, MB, Garcia, E, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Fahy, M, Lansky, AJ, Mehran, R, Stone, GW, and CADILLAC Investigators, . "Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial." Circulation 108, no. 11 (September 16, 2003): 1316-1323.  Full Text  Link to Item
    • Kandzari, DE, Labinaz, M, Cantor, WJ, Madan, M, Gallup, DS, Hasselblad, V, Joseph, D, Allen, A, Green, C, Hidinger, KG, Krucoff, MW, Christenson, RH, Harrington, RA, and Tcheng, JE. "Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial)." Am J Cardiol 92, no. 6 (September 15, 2003): 660-664.  Link to Item
    • Kong, DF, Hasselblad, V, Harrington, RA, White, HD, Tcheng, JE, Kandzari, DE, Topol, EJ, and Califf, RM. "Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions." The American Journal of Cardiology 92, no. 6 (September 2003): 651-655.  Full Text
    • Ellis, K, Tcheng, JE, Sapp, S, Topol, EJ, and Lincoff, AM. "Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials." J Interv Cardiol 16, no. 4 (August 2003): 299-305.  Link to Item
    • Shimpi, RA. "Low-molecular-weight heparins and glycoprotein IIb/IIIa inhibitors with percutaneous coronary intervention in acute coronary syndromes." J Invasive Cardiol 15, no. 8 (August 2003): 460-465. (Review)  Link to Item
    • Tcheng, JE, Madan, M, O'Shea, JC, Cohen, EA, Buller, CE, Lincoff, AM, Popma, JJ, Teirstein, PS, Kitt, MM, Lorenz, TJ, Greenberg, S, Fost, N, and Califf, RM. "Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention." Journal of Interventional Cardiology 16, no. 2 (April 2003): 97-105.  Full Text
    • Labinaz, M, Tcheng, JE, Pieper, K, Hafley, G, and O'Shea, C. "Comparison of one-year outcomes .. ESPRIT - Reply." AMERICAN JOURNAL OF CARDIOLOGY 91, no. 4 (February 15, 2003): 515-515.  Full Text  Link to Item
    • Tolleson, TR, O'Shea, JC, Bittl, JA, Hillegass, WB, Williams, KA, Levine, G, Harrington, RA, and Tcheng, JE. "Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial." J Am Coll Cardiol 41, no. 3 (February 5, 2003): 386-393.  Link to Item
    • Cannon, C, Driesman, M, Mehta, S, Rapaport, E, Moses, J, Tcheng, J, King, S, Waksman, R, and Bhatt, D. "Improving acute coronary syndrome care: The ACC/AHA guidelines and critical pathways." Journal of Invasive Cardiology 15, no. SUPPL. B (2003): 22B-29B.
    • Denardo, SJ, Davis, KE, Reid, PR, and Tcheng, JE. "Efficacy and safety of minimal dose (." The American journal of cardiology 91, no. 1 (January 2003): 1-5. (Academic Article)
    • Denardo, SJ, Davis, KE, Reid, PR, and Tcheng, JE. "Efficacy and safety of minimal dose (< or =1,000 units) unfractionated heparin with abciximab in percutaneous coronary intervention." Am J Cardiol 91, no. 1 (January 1, 2003): 1-5.  Link to Item
    • Kandzari, DE, and Tcheng, JE. "Double negatives." Am Heart J 145, no. 1 (January 2003): 9-11.  Full Text  Link to Item
    • Kereiakes, DJ, Tcheng, J, Fry, ETA, Bhatt, DL, Bosker, G, Diez, JG, III, JJF, Levine, GN, Schaer, GL, and Zidar, J. "Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: Evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS: The CATH (Cardiac Catheterization and Antithrombotic Therapy in the Hospital) Clinical Consensus Panel Report." Journal of Invasive Cardiology 15, no. 9 (2003): 536-553.
    • Reddan, DN, O'Shea, JC, Sarembock, IJ, Williams, KA, Pieper, KS, Santoian, E, Owen, WF, Kitt, MM, and Tcheng, JE. "Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial)." Am J Cardiol 91, no. 1 (January 1, 2003): 17-21.  Link to Item
    • Riesmeyer, JS, Reid, PR, Miller, DL, Labinaz, M, Tcheng, JE, Pieper, K, Hafley, G, and O'Shea, C. "Comparison of one-year outcomes. . . . ESPRIT." American Journal of Cardiology 91, no. 4 (2003): 514-515.  Full Text
    • Toffaletti, JG, McDonnell, EH, Welsby, I, Shearer, IR, Sketch, MH, and Tcheng, JE. "Implementing a New Method for Activated Clotting Time." Plastic Surgical Nursing 2, no. 2 (January 1, 2003): 125-128.
    • Wagner, CL, Schantz, A, Barnathan, E, Olson, A, Mascelli, MA, Ford, J, Damaraju, L, Schaible, T, Maini, RN, and Tcheng, JE. "Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade." Dev Biol (Basel) 112 (2003): 37-53.  Link to Item
    • Blankenship, JC, Balog, C, Sapp, SK, Califf, RM, Lincoff, AM, Tcheng, JE, and Topol, EJ. "Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials." Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions 57, no. 4 (December 2002): 476-483.  Full Text
    • Islam, MA, Blankenship, JC, Balog, C, Iliadis, EA, Lincoff, AM, Tcheng, JE, Califf, RM, Topol, EJ, and EPISTENT Investigators, . "Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)." The American Journal of Cardiology 90, no. 9 (November 2002): 916-921.  Full Text
    • Shah, SH, Sketch, MH, and Tcheng, JE. "Acute myocardial infarction in a young male while playing paintball." J Invasive Cardiol 14, no. 11 (November 2002): 713-715.  Link to Item
    • Dery, JP, O'Shea, JC, and Tcheng, JE. "Eptifibatide in percutaneous coronary intervention. A review." Minerva Cardioangiol 50, no. 5 (October 2002): 531-546. (Review)  Link to Item
    • Fernandes, LS, Tcheng, JE, O'Shea, JC, Weiner, B, Lorenz, TJ, Pacchiana, C, Berdan, LG, Maresh, KJ, Joseph, D, Madan, M, Mann, T, Kilaru, R, Hochman, JS, Kleiman, NS, and ESPRIT investigators, . "Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study." J Am Coll Cardiol 40, no. 6 (September 18, 2002): 1085-1091.  Link to Item
    • Batchelor, WB, Tolleson, TR, Huang, Y, Larsen, RL, Mantell, RM, Dillard, P, Davidian, M, Zhang, D, Cantor, WJ, Sketch, MH, Ohman, EM, Zidar, JP, Gretler, D, DiBattiste, PM, Tcheng, JE, Califf, RM, and Harrington, RA. "Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes." Circulation 106, no. 12 (September 17, 2002): 1470-1476.  Full Text
    • Batchelor, WB, Tolleson, TR, Huang, Y, Larsen, RL, Mantell, RM, Dillard, P, Davidian, M, Zhang, D, Cantor, WJ, Sketch, MH, Ohman, EM, Zidar, JP, Gretler, D, DiBattiste, PM, Tcheng, JE, Califf, RM, and Harrington, RA. "Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide." Circulation 106, no. 12 (September 2002): 1470-1476.  Full Text
    • Hillegass, WB, Brott, BC, Chapman, GD, Phillips, HR, Stack, RS, Tcheng, JE, and Califf, RM. "Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications." American Heart Journal 144, no. 3 (September 2002): 501-507.  Full Text
    • Holmes, DR, Savage, M, LaBlanche, J-M, Grip, L, Serruys, PW, Fitzgerald, P, Fischman, D, Goldberg, S, Brinker, JA, Zeiher, AM, Shapiro, LM, Willerson, J, Davis, BR, Ferguson, JJ, Popma, J, King, SB, Lincoff, AM, Tcheng, JE, Chan, R, Granett, JR, and Poland, M. "Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial." Circulation 106, no. 10 (September 2002): 1243-1250.  Full Text
    • Labinaz, M, Madan, M, O'Shea, JO, Kilaru, R, Chin, W, Pieper, K, McGuire, DK, Saucedo, JF, Talley, JD, Lui, H, Kitt, MM, Califf, RM, Tcheng, JT, and ESPRIT Investigators, . "Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial)." The American Journal of Cardiology 90, no. 6 (September 2002): 585-590.  Full Text
    • Kandzari, DE, Tcheng, JE, and Zidar, JP. "Coronary artery stents: evaluating new designs for contemporary percutaneous intervention." Catheter Cardiovasc Interv 56, no. 4 (August 2002): 562-576. (Review)  Full Text  Link to Item
    • O'Shea, JC, and Tcheng, JE. "Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa." Expert Opin Pharmacother 3, no. 8 (August 2002): 1199-1210. (Review)  Full Text  Link to Item
    • Gurm, HS, Brennan, DM, Booth, J, Tcheng, JE, Lincoff, AM, and Topol, EJ. "Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)." Am J Cardiol 90, no. 1 (July 1, 2002): 42-45.  Link to Item
    • Madan, M, Berkowitz, SD, Christie, DJ, Smit, AC, Sigmon, KN, and Tcheng, JE. "Determination of platelet aggregation inhibition during percutaneous coronary intervention with the platelet function analyzer PFA-100." Am Heart J 144, no. 1 (July 2002): 151-158.  Link to Item
    • Topol, EJ, Lincoff, AM, Kereiakes, DJ, Kleiman, NS, Cohen, EA, Ferguson, JJ, Tcheng, JE, Sapp, S, and Califf, RM. "Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization." The American Journal of Medicine 113, no. 1 (July 2002): 1-6.  Full Text
    • Dyke, CK, Benjamin, DK, Nelson, CL, Newby, K, O'shea, C, Cantor, W, Nguyen, C, Alexander, JH, Kitt, MM, and Tcheng, JE. "Elevated troponin following percutaneous coronary intervention predicts subsequent events: Results from the ESPRIT trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 39, no. 5 (March 6, 2002): 72A-72A.  Link to Item
    • Steinhubl, SR, Saucedo, JF, Sane, DC, Berger, PB, Moliterno, DJ, Tcheng, JE, and Kereiakes, DJ. "Point-of-care measurement of platelet function before angioplasty strongly predicts future target vessel revascularization." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 39, no. 5 (March 6, 2002): 72A-72A.  Link to Item
    • Sharayeva, ML, Tcheng, JE, and Cannon, CP. "Assessment of compliance with the American College of Cardiology/American Heart Association guidelines for patients with acute coronary syndromes admitted to a tertiary care hospital coronary care unit." Crit Pathw Cardiol 1, no. 1 (March 2002): 22-25.  Link to Item
    • Stone, GW, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Carroll, JD, Rutherford, BD, Lansky, AJ, and Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators, . "Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction." The New England Journal of Medicine 346, no. 13 (March 2002): 957-966.  Full Text
    • O'Shea, JC, Buller, CE, Cantor, WJ, Chandler, AB, Cohen, EA, Cohen, DJ, Gilchrist, IC, Kleiman, NS, Labinaz, M, Madan, M, Hafley, GE, Califf, RM, Kitt, MM, Strony, J, Tcheng, JE, and ESPRIT Investigators, . "Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention." Jama 287, no. 5 (February 2002): 618-621.  Full Text
    • Cohen, DJ, O'Shea, JC, Pacchiana, CM, Levine, G, Sarembock, I, Slater, J, Conn, E, Smith, J, Tcheng, JE, and ESPRIT investigators, . "In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin." Am J Cardiol 89, no. 1 (January 1, 2002): 61-64.  Link to Item
    • Cohen, DJ, O'Shea, JC, Pacchiana, CM, Levine, G, Sarembock, I, Slater, J, Conn, E, Smith, J, and Tcheng, JE. "In-hospital costs of coronary stent implantation with and without Eptifibatide (The ESPRIT Trial)." American Journal of Cardiology 89, no. 1 (2002): 61-64.  Full Text
    • Gibson, CM, Murphy, SA, Marble, SJ, Cohen, DJ, Cohen, EA, Lui, HK, Young, J, Kitt, MM, Lorenz, TJ, and Tcheng, JE. "Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy." Am Heart J 143, no. 1 (January 2002): 106-110.  Link to Item
    • Herrmann, HC, Stone, GW, Grines, CL, and Tcheng, JE. "Comparison of angioplasty with stenting in acute myocardial infarction [2] (multiple letters)." New England Journal of Medicine 347, no. 5 (2002): 367-368.  Full Text
    • Blankenship, JC, Sigmon, KN, Pieper, KS, O'Shea, C, Tardiff, BE, Tcheng, JE, and IMPACT-II Investigators, . "Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT--(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II Trial." Am J Cardiol 88, no. 9 (November 1, 2001): 969-973.  Link to Item
    • Tcheng, JE, Strony, J, Lorenz, TJ, and O'Shea, JC. "ESPRIT in context: pharmacology matters!." Eur Heart J 22, no. 21 (November 2001): 1965-1967.  Full Text  Link to Item
    • Tcheng, JE, Talley, JD, O'Shea, JC, Gilchrist, IC, Kleiman, NS, Grines, CL, Davidson, CJ, Lincoff, AM, Califf, RM, Jennings, LK, Kitt, MM, and Lorenz, TJ. "Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study)." The American Journal of Cardiology 88, no. 10 (November 2001): 1097-1102.  Full Text
    • Cohen, DJ, Cosgrove, RS, Berezin, RH, O'Shea, J, Kitt, MM, Gilchrist, I, Mark, DB, and Tcheng, JE. "Cost-effectiveness of eptifibatide in patients undergoing planned coronary stenting: Results from the ESPRIT trial." CIRCULATION 104, no. 17 (October 23, 2001): 386-387.  Link to Item
    • Quinn, MJ, Lincoff, AMM, Kereiakes, DJ, Kleiman, NS, Cohen, EA, Ferguson, JJ, Tcheng, JE, Califf, RM, and Topol, EJ. "Long-term mortality benefit of abciximab in percutaneous intervention." CIRCULATION 104, no. 17 (October 23, 2001): 387-387.  Link to Item
    • Rebeiz, AG, Pieper, KS, O'Shea, JC, Gilchrist, IC, Chandler, B, Slater, J, Muhlestein, JB, Lorenz, TJ, Joseph, D, Kitt, MM, and Tcheng, JE. "16 to 18-hour infusions of eptifibatide seem optimal in reducing ischemic complications following percutaneous coronary intervention." CIRCULATION 104, no. 17 (October 23, 2001): 386-386.  Link to Item
    • Tcheng, JE, Cohen, EA, Buller, CE, Cohen, DJ, Madan, M, Kitt, MM, Cantor, WJ, Lorenz, TJ, Hafley, G, Greenberg, S, and O'Shea, JC. "Eptifibatide (Integrilin (R)) in coronary stent implantation: Long-term results of the ESPRIT trial." CIRCULATION 104, no. 17 (October 23, 2001): 94-94.  Link to Item
    • Carcia, E, Cox, DA, Grines, CL, Stuckey, T, Tcheng, JE, Rutherford, BD, McLean, J, Carroll, J, Lansky, AJ, and Stone, GW. "Does primary stenting benefit proximal LAD infarction? The CADILLAC trial." AMERICAN JOURNAL OF CARDIOLOGY 88, no. 5A (September 11, 2001): 64G-64G.  Link to Item
    • Cox, DA, Grines, CL, Garcia, E, Stuckey, T, Tcheng, JE, Guagliumi, G, Johnson, A, Griffin, J, Lansky, A, and Stone, GW. "Does "Optimal" percutaneous transluminal coronary angioplasty (PTCA) provide equivalent outcomes in acute myocardial infarction (AMI) compared with stenting? Insights from the CADILLAC trial." AMERICAN JOURNAL OF CARDIOLOGY 88, no. 5A (September 11, 2001): 27G-27G.  Link to Item
    • Guagliumi, G, Cox, DA, Grines, CL, Garcia, E, Stuckey, T, Tcheng, JE, Pasquini, J, Carroll, J, Lansky, AJ, and Stone, GW. "Outcomes in elderly patients undergoing primary coronary intervention for AMI: Insights from the CADILLAC trial." AMERICAN JOURNAL OF CARDIOLOGY 88, no. 5A (September 11, 2001): 64G-65G.  Link to Item
    • Blankenship, JC, Tasissa, G, O'Shea, JC, Iliadis, EA, Bachour, FA, Cohen, DJ, Lui, HK, Mann, T, Cohen, E, Tcheng, JE, and ESPRIT Investigators, . "Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial." J Am Coll Cardiol 38, no. 3 (September 2001): 653-658.  Link to Item
    • Gurm, H, Tcheng, JE, Lincoff, AM, and Prosper, D. "Body mass index remains a significant predictor of outcome after percutaneous coronary interventions in the era of IIbIIIa inhibition." EUROPEAN HEART JOURNAL 22 (September 2001): 524-524.  Link to Item
    • O'Shea, JC, Cohen, EA, Buller, CE, Hafley, G, Kitt, MM, Lorenz, TJ, Califf, RM, Tcheng, JE, Madan, M, and Cohen, DJ. "Eptifibatide (Integrilin (R)) in coronary stent implantation: long-term results of the ESPRIT trial." EUROPEAN HEART JOURNAL 22 (September 2001): 121-121.  Link to Item
    • Tcheng, JE, Kereiakes, DJ, Lincoff, AM, George, BS, Kleiman, NS, Sane, DC, Cines, DB, Jordan, RE, Mascelli, MA, Langrall, MA, Damaraju, L, Schantz, A, Effron, MB, and Braden, GA. "Abciximab readministration: results of the ReoPro Readministration Registry." Circulation 104, no. 8 (August 21, 2001): 870-875.  Link to Item
    • Akkerhuis, KM, Deckers, JW, Lincoff, AM, Tcheng, JE, Boersma, E, Anderson, K, Balog, C, Califf, RM, Topol, EJ, and Simoons, ML. "Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention." Jama 286, no. 1 (July 2001): 78-82.  Full Text
    • Gehrig, TR, Sketch, MH, and Tcheng, JE. "No jacket required." J Invasive Cardiol 13, no. 7 (July 2001): 516-518.  Link to Item
    • Gilchrist, IC, O'Shea, JC, Kosoglou, T, Jennings, LK, Lorenz, TJ, Kitt, MM, Kleiman, NS, Talley, D, Aguirre, F, Davidson, C, Runyon, J, and Tcheng, JE. "Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention." Circulation 104, no. 4 (July 2001): 406-411.  Full Text
    • Cantor, WJ, Hellkamp, AS, Peterson, ED, Zidar, JP, Cowper, PA, Sketch, MH, Tcheng, JE, Califf, RM, and Ohman, EM. "Achieving optimal results with standard balloon angioplasty: can baseline and angiographic variables predict stent-like outcomes?." Journal of the American College of Cardiology 37, no. 7 (June 2001): 1883-1890.  Full Text
    • Gibson, CM, Cohen, DJ, Cohen, EA, Lui, HK, Murphy, SA, Marble, SJ, Kitt, M, Lorenz, T, and Tcheng, JE. "Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy." Am J Cardiol 87, no. 11 (June 1, 2001): 1293-1295.  Link to Item
    • O'Shea, JC, Hafley, GE, Greenberg, S, Hasselblad, V, Lorenz, TJ, Kitt, MM, Strony, J, Tcheng, JE, and ESPRIT Investigators (Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy trial), . "Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial." JAMA 285, no. 19 (May 16, 2001): 2468-2473.  Link to Item
    • O'Shea, JC, and Tcheng, JE. "Drug-company sponsorship and the Declaration of Helsinki - Reply." LANCET 357, no. 9266 (May 5, 2001): 1448-1449.  Full Text  Link to Item
    • Steinhubl, SR, Talley, JD, Braden, GA, Tcheng, JE, Casterella, PJ, Moliterno, DJ, Navetta, FI, Berger, PB, Popma, JJ, Dangas, G, Gallo, R, Sane, DC, Saucedo, JF, Jia, G, Lincoff, AM, Theroux, P, Holmes, DR, Teirstein, PS, and Kereiakes, DJ. "Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study." Circulation 103, no. 21 (May 2001): 2572-2578.  Full Text
    • Bachour, FA, Blankenship, JC, Iliadis, EA, Tasissa, G, O'Shea, JC, Kitt, MM, Lorenz, TJ, and Tcheng, JE. "Effect of glycoprotein IIb/IIIa receptor inhibition on in-lab adverse events and subsequent CK-MB elevation during percutaneous coronary intervention in ESPRIT." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 2001): 84A-84A.  Link to Item
    • Cantor, WJ, Hellkamp, AS, O'Shea, JC, Madan, M, Chisholm, RJ, Lorenz, TJ, Kitt, MM, Lui, H, Cohen, DJ, Feldman, R, Greene, R, and Tcheng, JE. "Bailout platelet GP IIb/IIIa inhibition in coronary stent implantation: Observations from the ESPRIT trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 2001): 84A-84A.  Link to Item
    • Chandler, B, O'Shea, JC, Greenberg, S, Slater, J, Kirshenbaum, JM, Muhlestein, JB, Pacchiana, CM, Lorenz, TJ, Raffetto, K, Kitt, MM, and Tcheng, JE. "Robust benefit of platelet GP IIb-IIIa inhibition with eptifibatide in patients undergoing stent PCI with hot or cold presentation." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 2001): 76A-77A.  Link to Item
    • Cohen, EA, Lincoff, M, Sapp, S, Burton, JR, Tcheng, JE, Topol, E, and Investigators, EPISTENT. "Variations in event rates between Canada and United States in the EPISTENT trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 2001): 81A-81A.  Link to Item
    • Grines, CL, Cox, DA, Tcheng, JE, Garcia, E, Stuckey, T, Carroll, J, Guagliumi, G, Rutherford, B, Esente, P, Lansky, AJ, Griffin, J, and Stone, GW. "Effect of stent implantation and glycoprotein IIb/IIIa receptor blockade on TIMI flow and mortality after primary PTCA in acute myocardial infarction: Final results of the CADILLAC Trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 2001): 342S-342S.  Link to Item
    • Madan, M, Berkowitz, SD, Christie, DJ, Jennings, LK, Smit, AC, Sigmon, KN, Glazer, S, and Tcheng, JE. "Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention." Am Heart J 141, no. 2 (February 2001): 226-233.  Full Text  Link to Item
    • O'Shea, JC, Mann, T, Hellkamp, A, Cohen, E, Chisholm, R, Cantor, WJ, Gilchrist, I, Meengs, W, Kitt, MM, Lorenz, TJ, and Tcheng, JE. "Fewer bleeding complications with comparable efficacy with the transradial approach in coronary artery stenting: An analysis of the ESPRIT trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 2001): 33A-33A.  Link to Item
    • O'Shea, JC, and Tcheng, JE. "Eptifibatide in Percutaneous Coronary Intervention: The ESPRIT Trial Results." Curr Interv Cardiol Rep 3, no. 1 (February 2001): 62-68.  Link to Item
    • Reddan, DN, O'Shea, JC, Williams, K, Lorenz, T, Kitt, M, Santoian, E, Levine, G, Sarembock, L, Owen, WF, and Tcheng, JE. "Treatment effect at different levels of creatinine clearance following eptifibatide in planned coronary stent implantation." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 2001): 11A-11A.  Link to Item
    • Stone, GW, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Stuckey, T, Carroll, J, Guagliumi, G, Rutherford, B, Johnson, G, Effron, M, Esente, P, Lansky, AJ, and Griffin, J. "A prospective, multicenter, international randomized trial comparing four reperfusion strategies in acute myocardial infarction: Principal report of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 2001): 342S-342S.  Link to Item
    • Stuckey, T, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Carroll, J, Rutherford, B, Guagliumi, G, Esente, P, Lansky, AJ, Griffin, J, and Stone, GW. "Does stenting and glycoprotein IIb/IIIa receptor blockade improve the prognosis of diabetics undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 2001): 342S-342S.  Link to Item
    • Tcheng, JE, Effron, M, Grines, CL, Garcia, E, Cox, D, Stuckey, T, Carroll, J, Guagliumi, G, Rutherford, B, Lansky, AJ, Esente, P, Griffin, J, and Stone, GW. "Abciximab use during percutaneous intervention in patients with acute myocardial infarction improves early and late clinical outcomes: Final results of the CADILLAC trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 2001): 343A-343A.  Link to Item
    • Tcheng, JE, O'Shea, JC, Cohen, EA, Buller, CE, Lincoff, AM, Joseph, D, Teirstein, PS, Pacchiana, CM, Hafley, G, Lorenz, TJ, Kitt, MM, and Califf, RM. "High-dose eptifibatide (Integrilin (R)) in coronary stent implantation: 1 year results of the ESPRIT trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 2001): 76A-76A.  Link to Item
    • Brown, DL, O'Shea, JC, and Tcheng, JE. "Drug-company sponsorship and the Declaration of Helsinki [10] (multiple letters)." Lancet 357, no. 9266 (2001): 1448-1449.
    • Gibson, CM, Cohen, DJ, Cohen, EA, Lui, HK, Murphy, SA, Marble, SJ, Kitt, M, Lorenz, T, and Tcheng, JE. "Effect of Eptifibatide on coronary flow reserve following coronary stent implantation (An ESPRIT substudy)." American Journal of Cardiology 87, no. 11 (2001): 1293-1295.  Full Text
    • TCHENG, J. "Abciximab readministration results of the ReoPro Readministration Registry." Circulation 104 (2001): 870-875.  Full Text
    • Tcheng, JE, and Volkert-Noethen, AA. "Current multicentre studies with the excimer laser: design and aims." Lasers Med Sci 16, no. 2 (2001): 122-129. (Review)  Link to Item
    • Lincoff, AM, Mark, DB, Tcheng, JE, Califf, RM, Bala, MV, Anderson, KM, Davidson-Ray, L, Knight, JD, Cabot, CF, and Topol, EJ. "Economic Assessment of Platelet Glycoprotein IIb/IIIa Receptor Blockade With Abciximab and Low-Dose Heparin During Percutaneous Coronary Revascularization : Results From the EPILOG Randomized Trial." Circulation 102, no. 24 (December 12, 2000): 2923-2929.  Full Text
    • ESPRIT Investigators. Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy, . "Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial." Lancet (London, England) 356, no. 9247 (December 2000): 2037-2044.  Full Text
    • Lincoff, AM, Mark, DB, Tcheng, JE, Califf, RM, Bala, MV, Anderson, KM, Davidson-Ray, L, Knight, JD, Cabot, CF, and Topol, EJ. "Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade." Circulation 102, no. 24 (December 2000): 2923-2929.  Full Text
    • O'Shea, JC, and Tcheng, JE. "Small-molecule glycoprotein IIb/IIIa inhibitors as adjunctive therapy in percutaneous coronary interventions." J Thromb Thrombolysis 10, no. 3 (December 2000): 211-215. (Review)  Link to Item
    • O'shea, JC, Madan, M, Cantor, WJ, Pacchiana, CM, Greenberg, S, Joseph, DM, Kitt, MM, Lorenz, TJ, and Tcheng, JE. "Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention." Am Heart J 140, no. 6 (December 2000): 834-839.  Full Text  Link to Item
    • Burris, N, Lippincott, RA, Elfe, A, Tcheng, JE, O'Shea, JC, and Reiser, C. "Effects of 308 nanometer excimer laser energy on 316 L stainless-steel stents: implications for laser atherectomy of in-stent restenosis." J Invasive Cardiol 12, no. 11 (November 2000): 555-559.  Link to Item
    • Denardo, SJ, Davis, KE, Tcheng, JE, and Reid, PR. "Extremely low dose heparin with abciximab in coronary intervention: Improved efficacy and decreased bleeding complications using a novel heparin dosing strategy." CIRCULATION 102, no. 18 (October 31, 2000): 785-785.  Link to Item
    • Fernandes, LS, Tcheng, JE, Kleiman, NS, Weiner, BH, Lorenz, TJ, Pacchiana, C, O'Shea, JC, Berdan, LG, Joseph, D, Madan, M, Mann, T, and Hochman, JS. "Eptifibatide is as effective in women as in men: Lessons from the ESPRIT trial." CIRCULATION 102, no. 18 (October 31, 2000): 785-785.  Link to Item
    • Gibson, CM, Cohen, DJ, Cohen, EA, Lui, H, Luu, L, Hynes, C, Saunders, T, Kliris, J, Kermgard, S, Otten, M, Kitt, MM, and Tcheng, JE. "Eptifibatide improves coronary flow reserve following stent placement: An ESPRIT substudy." CIRCULATION 102, no. 18 (October 31, 2000): 366-366.  Link to Item
    • Gilchrist, IC, Pacchiana, CM, Cantor, WJ, Blankenship, JC, Seidelin, P, Ducas, J, Sheldon, W, Tannenbaum, MA, Smith, JE, O'Shea, JC, Lorenz, TJ, and Tcheng, JE. "Temporal spectrum of ischemic complications with percutaneous coronary intervention: The ESPRIT experience." CIRCULATION 102, no. 18 (October 31, 2000): 640-640.  Link to Item
    • Labinaz, M, Madan, M, McGuire, DK, Batchelor, W, Saucedo, J, Pacchiana, C, Kitt, MM, O'Shea, JC, Talley, DJ, Liu, H, Timmis, S, and Tcheng, JE. "Effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, among diabetic patients following coronary stenting: Results from ESPRIT." CIRCULATION 102, no. 18 (October 31, 2000): 665-+.  Link to Item
    • Steinhubl, SR, Talley, JD, Kereiakes, DJ, Braden, GA, Tcheng, JE, Casterella, PJ, Moliterno, DJ, Navetta, FI, Berger, PB, Popma, JJ, Dangas, GD, and Theroux, P. "Correlates of baseline platelet function as measured by the Ultegra-RPFA and its asssociation with the level of platelet inhibition achieved with GPIIb/IIIa inhibitor therapy. Results from the GOLD study." CIRCULATION 102, no. 18 (October 31, 2000): 418-419.  Link to Item
    • Stone, GW, Grines, CL, Cox, DA, Stuckey, T, Carroll, JD, Guagliumi, G, Rutherford, BD, Essente, P, Lansky, AJ, Tcheng, JE, Griffin, J, and Garcia, E. "A prospective, randomized trial comparing primary balloon angioplasty with or without abciximab to primary stenting with or without abciximab in acute myocardial infarction - Primary endpoint analysis from the CADILLAC Trial." CIRCULATION 102, no. 18 (October 31, 2000): 664-+.  Link to Item
    • Tcheng, JE, Cohen, EA, Buller, CEH, Lincoff, AM, Joseph, D, Teirstein, PS, Pacchiana, CM, Madan, M, Cantor, WJ, Lorenz, TJ, Kitt, MM, and O'Shea, JC. "High-dose eptifibatide (Integrilln (R)) in coronary stent implantation: 6 month results of the ESPRIT trial." CIRCULATION 102, no. 18 (October 31, 2000): 663-663.  Link to Item
    • Tolleson, TR, Bittl, J, O'Shea, JC, Saucedo, J, Levine, G, Lopez, M, Kitt, MM, Lorenz, TJ, Blankenship, JC, Pacchiana, CM, Natarajan, M, and Tcheng, JE. "Relationship between maximum procedural act and safety/efficacy in ESPRIT/IMPACT II." CIRCULATION 102, no. 18 (October 31, 2000): 665-665.  Link to Item
    • Wightman, MB, Bindal, V, Cowper, PA, Muhlbaier, LH, Warwrzynski, R, Tcheng, JE, Sketch, MH, Ryan, T, and Peterson, ED. "Limitations in the APRDRG as a measure of severity." CIRCULATION 102, no. 18 (October 31, 2000): 877-877.  Link to Item
    • O'Shea, JC, Lorenz, TJ, Joseph, D, Kitt, MM, Greenberg, S, Lui, H, Cantor, W, Cohen, E, and Tcheng, JE. "Robust benefit of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing stent percutaneous coronary intervention with positive cardiac markers at baseline." AMERICAN JOURNAL OF CARDIOLOGY 86, no. 8A (October 16, 2000): 13I-14I.  Link to Item
    • Cantor, WJ, Peterson, ED, Popma, JJ, Zidar, JP, Sketch, MH, Tcheng, JE, and Ohman, EM. "Provisional stenting strategies: systematic overview and implications for clinical decision-making." J Am Coll Cardiol 36, no. 4 (October 2000): 1142-1151. (Review)  Link to Item
    • Kandzari, DE, Tcheng, JE, Harrington, RA, and Sketch, MH. ""Rescue" platelet GP IIb/IIIa inhibitor therapy in percutaneous coronary intervention: bailing out of a sunken ship." J Invasive Cardiol 12, no. 10 (October 2000): 502-504.  Link to Item
    • Cho, L, Topol, EJ, Balog, C, Foody, JM, Booth, JE, Cabot, C, Kleiman, NS, Tcheng, JE, Califf, R, and Lincoff, AM. "Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender: Pooled analysis from EPIC, EPILOG and epistent trials." Journal of the American College of Cardiology 36, no. 2 (August 29, 2000): 381-386.  Full Text
    • Cho, L, Topol, EJ, Balog, C, Foody, JM, Booth, JE, Cabot, C, Kleiman, NS, Tcheng, JE, Califf, R, and Lincoff, AM. "Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent." J Am Coll Cardiol 36, no. 2 (August 2000): 381-386.  Link to Item
    • Lincoff, AM, LeNarz, LA, Despotis, GJ, Smith, PK, Booth, JE, Raymond, RE, Sapp, SK, Cabot, CF, Tcheng, JE, Califf, RM, Effron, MB, and Topol, EJ. "Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing." Ann Thorac Surg 70, no. 2 (August 2000): 516-526.  Link to Item
    • Liptay, MJ, Masters, GA, Winchester, DJ, Edelman, BL, Garrido, BJ, Hirschtritt, TR, Perlman, RM, and Fry, WA. "Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer." The Annals of Thoracic Surgery 70, no. 2 (August 2000): 384-389.  Full Text
    • Madan, M, and Tcheng, JE. "Update on Abciximab Readministration During Percutaneous Coronary Interventions." Curr Interv Cardiol Rep 2, no. 3 (August 2000): 244-249.  Link to Item
    • Kereiakes, DJ, Berkowitz, SD, Lincoff, AM, Tcheng, JE, Wolski, K, Achenbach, R, Melsheimer, R, Anderson, K, Califf, RM, and Topol, EJ. "Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade." American Heart Journal 140, no. 1 (July 2000): 74-80.  Full Text
    • Tcheng, JE. "High-dose eptifibatide in elective coronary stenting: Results of the ESPRIT trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 36, no. 1 (July 2000): 321-321.  Link to Item
    • Bhatt, DL, Lincoff, AM, Califf, RM, Simoons, ML, Tcheng, JE, Brener, SJ, Wolski, KE, and Topol, EJ. "The benefit of abciximab in percutaneous coronary revascularization is not device-specific." The American Journal of Cardiology 85, no. 9 (May 2000): 1060-1064.  Full Text
    • Tanguay, JF, Cantor, WJ, Krucoff, MW, Muhlestein, B, Barsness, GW, Zidar, JP, Sketch, MH, Tcheng, JE, Phillips, HR, Stack, RS, Kaplan, AV, and Ohman, EM. "Local delivery of heparin post-PTCA: a multicenter randomized pilot study." Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions 49, no. 4 (April 2000): 461-467.  Full Text
    • Cohen, MG, Kong, DF, Warner, JJ, Wightman, MB, Greenbaum, AB, Tcheng, JE, Peter, RH, Sketch, MH, Muhlbaier, LH, and Zidar, JP. "Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents." Am J Cardiol 85, no. 4 (February 15, 2000): 446-450.  Link to Item
    • Madan, M, Kereiakes, DJ, Hermiller, JB, Rund, MM, Tudor, G, Anderson, L, McDonald, MB, Berkowitz, SD, Sketch, MH, Phillips, HR, and Tcheng, JE. "Efficacy of abciximab readministration in coronary intervention." Am J Cardiol 85, no. 4 (February 15, 2000): 435-440.  Link to Item
    • Bhatt, DL, Lincoff, AM, Tcheng, JE, Califf, RM, L'Allier, PL, Marso, SP, Wolski, KE, Kereiakes, DJ, and Topol, EJ. "The impact of abciximab on mortality after multivessel PCI: A striking effect in diabetics." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 35, no. 2 (February 2000): 91A-91A.  Link to Item
    • Kereiakes, DJ, Berkowitz, SD, Lincoff, AM, Tcheng, JE, Wolski, K, Califf, RM, and Topol, EJ. "Abciximab thrombocytopenia: Clinical correlates and outcomes." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 35, no. 2 (February 2000): 91A-92A.  Link to Item
    • Tcheng, JE. "Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment." American Heart Journal 139, no. 2 Pt 2 (February 2000): S38-S45. (Review)  Full Text
    • Tcheng, JE. "Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: Bleeding, reversal, thrombocytopenia, and retreatment." AMERICAN HEART JOURNAL 139, no. 2 (February 2000): S38-S45.  Full Text  Link to Item
    • Thel, MC, Califf, RM, Tardiff, BE, Gardner, LH, Sigmon, KN, Lincoff, A, Topol, EJ, Kitt, MM, Blankenship, JC, and Tcheng, JE. "Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II)." The American Journal of Cardiology 85, no. 4 (February 2000): 427-434.  Full Text
    • Thel, MC, Califf, RM, Tardiff, BE, Gardner, LH, Sigmon, KN, Lincoff, AM, Topol, EJ, Kitt, MM, Blankenship, JC, and Tcheng, JE. "Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis." The American Journal of Cardiology 85, no. 4 (February 2000): 427-434.  Full Text
    • Huay-Cheem, TAN, Crowley, J, Tcheng, JE, Li-Wah, SNG, Jr, MHS, Phillips, HR, Peter, RH, Behar, VS, Stack, RS, and Zidar, JP. "Treatment of Palmaz-Schatz in-stent restenosis: 6-Month clinical follow-up." Journal of Interventional Cardiology 13, no. 5 (2000): 315-322.
    • Steinhubl, S, Talley, D, Kereiakes, DJ, Braden, GA, Tcheng, JE, Casterella, PJ, Moliterno, DJ, Berger, PB, and Topol, EJ. "The level of platelet inhibition maintained with a GPIIb/IIIa inhibitor following coronary intervention is strongly associated with the risk of a post-procedural MACE: results of the GOLD study." EUROPEAN HEART JOURNAL 21 (2000): 145-145.  Link to Item
    • Tcheng, JE. "Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: Bleeding, reversal, thrombocytopenia, and retreatment." American Heart Journal 139, no. 2 II (2000): S38-S45.
    • Madan, M, and Tcheng, JE. "Coronary intervention and glycoprotein IIb/IIIa integrin blockade." Coron Artery Dis 10, no. 8 (December 1999): 553-560. (Review)  Link to Item
    • Pracyk, JB, Drennan, S, and Tcheng, JE. "Hemostasis of the femoral vasculature: Shouldn't we have an answer by now?." Am Heart J 138, no. 6 Pt 1 (December 1999): 1014-1015.  Link to Item
    • Pracyk, JB, Drennan, S, and Tcheng, JE. "Hemostasis of the femoral vasculature: Shouldn't we have an answer by now?." AMERICAN HEART JOURNAL 138, no. 6 (December 1999): 1014-1015.  Full Text  Link to Item
    • Marks, DS, Effron, MB, Mensah, GA, Fitzpatrick, SE, Tcheng, JE, and Kereiakes, DF. "Abciximab markedly reduces 30-day adverse outcomes in black patients undergoing coronary intervention." CIRCULATION 100, no. 18 (November 2, 1999): 104-104.  Link to Item
    • Roe, MT, Gum, PA, Booth, JE, Jia, G, Damaraju, L, Fitzpatrick, SE, Kereiakes, DJ, and Tcheng, JE. "Consistent and durable reduction in death and myocardial infarction with abciximab during coronary intervention in acute coronary syndromes and stable angina: A pooled analysis from EPIC, EPILOG, and EPISTENT." CIRCULATION 100, no. 18 (November 2, 1999): 187-187.  Link to Item
    • Gilchrist, IC, Gardner, LH, Muhlestein, JB, Arnold, AM, Lincoff, AM, Califf, RM, Tcheng, JE, and Topol, EJ. "Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experience." Am Heart J 138, no. 5 Pt 1 (November 1999): 976-982.  Link to Item
    • Gilchrist, IC, Gardner, LH, Muhlestein, JB, Arnold, AM, Lincoff, AM, Califf, RM, Tcheng, JE, and Topol, EJ. "Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experience." American Heart Journal 138, no. 5 Pt 1 (November 1999): 976-982.  Full Text
    • Tcheng, JE, and O'Shea, JC. "Eptifibatide: a potent inhibitor of the platelet receptor integrin, glycoprotein IIb/IIIa." Expert Opin Investig Drugs 8, no. 11 (November 1999): 1893-1905.  Link to Item
    • Tcheng, JE, and Kong, DF. "Vale, warfarin: a stentorian farewell." Am Heart J 138, no. 4 Pt 1 (October 1999): 602-605.  Link to Item
    • Tcheng, JE. "A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes." Am Heart J 138, no. 4 Pt 2 (October 1999): 261-262.  Link to Item
    • Anderson, KM, Cabot, CF, and Tcheng, JE. "Abciximab reduces in-hospital events among patients undergoing percutaneous coronary intervention." AMERICAN JOURNAL OF CARDIOLOGY 84, no. 6A (September 22, 1999): 67P-67P.  Link to Item
    • Cabot, CF, Anderson, KM, Tcheng, JE, and Lincoff, AM. "Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention." AMERICAN JOURNAL OF CARDIOLOGY 84, no. 6A (September 22, 1999): 71P-71P.  Link to Item
    • Madan, M, Berkowitz, SD, Christie, DJ, Jennings, LK, Smit, AC, Sigmon, KN, Glazer, S, and Tcheng, JE. "Rapid assessment of GP IIb/IIIa blockade: An evaluation of PFA-100 (R) as a point-of-care technology during percutaneous coronary interventions (PCI)-checkpoint study." THROMBOSIS AND HAEMOSTASIS (August 1999): 358-359.  Link to Item
    • O'Shea, C, and Tcheng, JE. "Platelet glycoprotein IIb/IIIa integrin inhibition in acute myocardial infarction." J Invasive Cardiol 11, no. 8 (August 1999): 494-499. (Review)  Link to Item
    • Lincoff, AM, Califf, RM, Moliterno, DJ, Ellis, SG, Ducas, J, Kramer, JH, Kleiman, NS, Cohen, EA, Booth, JE, Sapp, SK, Cabot, CF, and Topol, EJ. "Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators." The New England Journal of Medicine 341, no. 5 (July 1999): 319-327.  Full Text
    • Tcheng, JE, Kereiakes, DJ, Braden, GA, Jordan, RE, Mascelli, MA, Langrall, MA, and Effron, MB. "Readministration of abciximab: interim report of the ReoPro readministration registry." Am Heart J 138, no. 1 Pt 2 (July 1999): S33-S38.  Link to Item
    • Tcheng, JE. "Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment." Am J Cardiol 83, no. 9A (May 6, 1999): 7E-11E.  Link to Item
    • Lincoff, AM, Tcheng, JE, Califf, RM, Kereiakes, DJ, Kelly, TA, Timmis, GC, Kleiman, NS, Booth, JE, Balog, C, Cabot, CF, Anderson, KM, Weisman, HF, and Topol, EJ. "Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade." Circulation 99, no. 15 (April 1999): 1951-1958.  Full Text
    • Thel, MC, Califf, RM, Tcheng, JE, Sigmon, KN, Lincoff, AM, Topol, EJ, and Ellis, SG. "Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators." American Heart Journal 137, no. 2 (February 1999): 264-273.  Full Text
    • Kleiman, NS, and Tcheng, JE. "Safety issues surrounding use of platelet GP IIb/IIIa antagonists: Reversibility and readministration." European Heart Journal, Supplement 1, no. E (1999): E36-E42.
    • Pracyk, JB, Drennan, S, and Tcheng, JE. "Hemostasis of the femoral vasculature: Shouldn't we have an answer by now?." American Heart Journal 138, no. 6 I (1999): 1014-1015.
    • TCHENG, J. "Readministration of abciximab : interim report of the ReoPro readministration registry." Am Heart J. 138 (1999): S33-S38.  Full Text
    • Tardiff, BE, Califf, RM, Tcheng, JE, Lincoff, A, Sigmon, KN, Harrington, RA, Mahaffey, KW, Ohman, E, Teirstein, PS, Blankenship, JC, Kitt, MM, and Topol, EJ. "Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention." Journal of the American College of Cardiology 33, no. 1 (January 1999): 88-96.  Full Text
    • Tardiff, BE, Califf, RM, Tcheng, JE, Lincoff, AM, Sigmon, KN, Harrington, RA, Mahaffey, KW, Ohman, EM, Teirstein, PS, Blankenship, JC, Kitt, MM, and Topol, EJ. "Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II." Journal of the American College of Cardiology 33, no. 1 (January 1999): 88-96.  Full Text
    • Tcheng, JE, Kereiakes, DJ, Braden, GA, Jordan, RE, Mascelli, MA, Langrall, MA, and Effron, MB. "Readministration of abciximab: Interim report of the ReoPro readministration registry." American Heart Journal 138, no. 1 II (1999): S33-S38.  Full Text
    • Tcheng, JE, and Kong, DF. "Vale, warfarin: A stentorian farewell." American Heart Journal 138, no. 4 I (1999): 602-605.  Full Text
    • Tcheng, JE. "Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment." American Journal of Cardiology 83, no. 9 A (1999): 7E-11E.
    • Tcheng, JE. "A symposium: Safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes." American Heart Journal 138, no. 4 II (1999): S261-S262.  Full Text
    • Madan, M, Berkowitz, SD, and Tcheng, JE. "Glycoprotein IIb/IIIa integrin blockade." Circulation 98, no. 23 (December 8, 1998): 2629-2635. (Review)  Link to Item
    • "Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial." Journal of the American College of Cardiology 32, no. 7 (December 1998): 2003-2010.
    • Kong, DF, Califf, RM, Miller, DP, Moliterno, DJ, White, HD, Harrington, RA, Tcheng, JE, Lincoff, AM, Hasselblad, V, and Topol, EJ. "Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease." Circulation 98, no. 25 (December 1998): 2829-2835.  Full Text
    • Ellis, SG, Lincoff, AM, Miller, D, Tcheng, JE, Kleiman, NS, Kereiakes, D, Califf, R, and Topol, EJ. "Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Blockade." J Am Coll Cardiol 32, no. 6 (November 15, 1998): 1619-1623.  Link to Item
    • Bhatt, DL, Lincoff, AM, Kereiakes, DJ, Tcheng, JE, Simoons, ML, van der Wieken, LR, Godfrey, N, Califf, RM, and Topol, EJ. "Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention." The American Journal of Cardiology 82, no. 9 (November 1998): 1105-A6.  Full Text
    • Ellis, SG, Lincoff, A, Miller, D, Tcheng, JE, Kleiman, NS, Kereiakes, D, Califf, R, and Topol, EJ. "Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology." Journal of the American College of Cardiology 32, no. 6 (November 1998): 1619-1623.  Full Text
    • Blankenship, JC, Godfrey, NK, Balog, G, Demko, SL, and Tcheng, JE. "How did Aciximab decrease ischemic complications during coronary intervention in EPISTENT? Analysis of in-lab adverse events." CIRCULATION 98, no. 17 (October 27, 1998): 573-573.  Link to Item
    • Gilchrist, IC, Thel, MC, Joseph, D, Zimmerman, HE, Jennings, LK, Kleiman, NS, Kerelakes, DJ, Talley, JD, O'Brien, MA, Lorenz, T, and Tcheng, JE. "Enhanced platelet IIb/IIIa inhibition with eptifibatide via high-dose, double-bolus dosing: Final results of the PRIDE study." CIRCULATION 98, no. 17 (October 27, 1998): 844-845.  Link to Item
    • Lincoff, AM, Tcheng, JE, Califf, RM, Cabot, CF, Booth, JE, Godfrey, NK, and Topol, EJ. "The EPISTENT trial at 6 months: Relative and combined effects of abciximab and stenting on reduction of acute ischemic events and late revascularization." CIRCULATION 98, no. 17 (October 27, 1998): 767-767.  Link to Item
    • Tcheng, JE, Kereiakes, DJ, Braden, GA, Lincoff, AM, Mascelli, MA, Langrall, MA, Damaraju, LV, Schantz, AR, Barnathan, ES, and Effron, MB. "Safety of abciximab retreatment - Final clinical report of the ReoPro readministration registry (R-3)." CIRCULATION 98, no. 17 (October 27, 1998): 17-17.  Link to Item
    • Kereiakes, DJ, Lincoff, AM, Simoons, ML, deBoer, MJ, Tcheng, JE, Vahanian, A, Anderson, KM, Cabot, CF, and Califf, RM. "Abciximab benefit in coronary intervention has no gender bias: Results of EPIC, EPILOG and CAPTURE trials." AMERICAN JOURNAL OF CARDIOLOGY 82, no. 7A (October 1998): 95S-95S.  Link to Item
    • Adelman, AG, Caramori, PR, Cohen, EA, Chisholm, RJ, Côté, G, Ducas, J, O'Neill, BJ, and Tcheng, JE. "The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent era." Can J Cardiol 14, no. 8 (August 1998): 1057-1066. (Review)  Link to Item
    • Berkowitz, SD, Sane, DC, Sigmon, KN, Shavender, JH, Harrington, RA, Tcheng, JE, Topol, EJ, and Califf, RM. "Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group." Journal of the American College of Cardiology 32, no. 2 (August 1998): 311-319.  Full Text
    • Berkowitz, SD, Sane, DC, Sigmon, KN, Shavender, JH, Harrington, RA, Tcheng, JE, Topol, EJ, and Califf, RM. "Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization." Journal of the American College of Cardiology 32, no. 2 (August 1998): 311-319.  Full Text
    • Topol, EJ, Lincoff, AM, Califf, RM, Tcheng, JE, Kleiman, NS, Adelman, AG, Burton, JR, Talley, JD, Ivanhoe, RJ, Ducas, C, Cheung, PK, Schick, U, Badard, D, Kramer, J, Leary, J, Snyder, H, Wilson, R, Dearen, M, Caramori, P, Webber, S, Taylor, J, Ferrando, T, Cohen, E, Balleza, L, Rouse, C, Hogg, N, Kelly, T, Alston, S, Webb, J, Buller, E, Ricci, DR, Mockman, S, Tanguay, JF, Poitras, AM, Timis, G, Davey, D, Coleman, P, Herrold-Runge, P, O'Neill, BJ, Foshey, K, Fitzgerald, N, Almond, D, Kostuk, W, White, J, Oskalns, R, Gottlieb, R, Koren, P, Palazzo, D, Azrin, M, Barry, MB, Blankenship, J, Demko, SL, Kraft, P, Dvorak, L, Brown, R, Colclough, M, Stevens, K, Sarembock, I, Snyder, L, Sayre, S, Browne, K, Roy, M, Reen, B, Short, R, Thompson, M, Chiodo, V, Hoffman, D, Bass, TA, Zenni, M, Rohman, G, Marquis, JF, Labinaz, M, Jelley, J, French, W, Goldberg, S, Wang, S, Gradman, A, Boltey, L, Collins, J, Worley, S, Hollywood, L, Frey, L, Yakubov, S, Gilliland, C, Rodriguez, A, Potter, K, Taylor, M, Aji, J, Cleary, E, Tannenbaum, M, Hartz, A, Rund, M, Smigley, R, Lopez, J, Kunny, P, Hochman, J, Slater, J, Termey, D, Bates, E, Fox-Bruenger, P, Gonzalez, M, Jopperri, L, Runyon, JP, Higby, N, Krucoft, M, Booth, T, Aguirre, F, Bach, R, Mechem, C, Murphy, D, Cummins, FE, Nonweiler, J, Sanz, M, Cole, C, Weston, MW, Anderson, HV, Weigelt, L, Larkin, T, Jackson, BJ, Rosenberg, MJ, Tully, S, Hartman, C, Lunow, S, Lucore, C, Mishkel, G, McShane, K, Muhlestein, B, Jerman, J, Sander, G, Stevens, A, Chisholm, R, Del Core, M, Stengel, L, Cannata, R, Castle, V, DeLuca, S, Balog, C, Knuth, T, McCollough, T, Godfrey, N, Melton, J, Miller, D, Pulliam, M, Sapp, S, Sigmon, KN, Templin, M, Montague, E, Carlson, J, Heil, L, Zovkic, V, Malone, K, Rodkey, S, Haas, G, Harrington, R, Kapadis, S, Campbell, L, Mukherjee, D, Deedy, M, Augostini, R, Alexander, J, Whellan, D, Bajzer, C, Rabbani, R, Clemons, P, Baishnab, R, Randall, R, Underwood, D, Lauer, MA, Lauer, MS, Roe, M, Farhy, R, Schweikert, R, Grady, T, Ellis, S, Moliterno, D, Debowey, D, Ivanc, T, Ols, L, Poliszcuk, R, Balazs, E, Witherspoon, B, Anderson, KM, Barnathan, E, Cabot, CF, Stoner, GL, and Weisman, HF. "Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade." Lancet 352, no. 9122 (July 11, 1998): 87-92. (Academic Article)  Full Text  Link to Item
    • Mandak, JS, Blankenship, JC, Gardner, LH, Berkowitz, SD, Aguirre, FV, Sigmon, KN, Timmis, GC, Gilchrist, IC, McIvor, M, Resar, J, Weiner, BH, George, BS, Talley, J, Lincoff, A, Tcheng, JE, Califf, RM, and Topol, EJ. "Modifiable Risk Factors for Vascular Access Site Complications in the IMPACT II Trial of Angioplasty With Versus Without Eptifibatide." Journal of the American College of Cardiology 31, no. 7 (June 1998): 1518-1524.  Full Text
    • Mandak, JS, Blankenship, JC, Gardner, LH, Berkowitz, SD, Aguirre, FV, Sigmon, KN, Timmis, GC, Gilchrist, IC, McIvor, M, Resar, J, Weiner, BH, George, BS, Talley, JD, Lincoff, AM, Tcheng, JE, Califf, RM, and Topol, EJ. "Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis." Journal of the American College of Cardiology 31, no. 7 (June 1998): 1518-1524.  Full Text
    • Oesterle, SN, Bittl, JA, Leon, MB, Hamburger, J, Tcheng, JE, Litvack, F, Margolis, J, Gilmore, P, Madsen, R, Holmes, D, Moses, J, Cohen, H, King, S, Brinker, J, Hale, T, Geraci, DJ, Kerker, WJ, and Popma, J. "Laser wire for crossing chronic total occlusions: "learning phase" results from the U.S. TOTAL trial. Total Occlusion Trial With Angioplasty by Using a Laser Wire." Catheterization and Cardiovascular Diagnosis 44, no. 2 (June 1998): 235-243.  Full Text
    • Oesterle, SN, Bittl, JA, Leon, MB, Hamburger, J, Tcheng, JE, Litvack, F, Margolis, J, Gilmore, P, Madsen, R, Holmes, D, Moses, J, Cohen, H, King, S, Brinker, J, Hale, T, Geraci, DJ, Kerker, WJ, and Popma, J. "Laser wire for crossing chronic total occlusions: 'Learning phase' results from the U.S. TOTAL trial." Catheterization and Cardiovascular Diagnosis 44, no. 2 (June 1, 1998): 235-243.  Full Text
    • Pracyk, JB, Wall, TC, Longabaugh, JP, Tice, FD, Hochrein, J, Green, C, Cox, G, Lee, K, Stack, RS, and Tcheng, JE. "A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention." Am J Cardiol 81, no. 8 (April 15, 1998): 970-976.  Link to Item
    • Kereiakes, DJ, Lincoff, AM, Miller, DP, Tcheng, JE, Cabot, CF, Anderson, KM, Weisman, HF, Califf, RM, and Topol, EJ. "Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators." Circulation 97, no. 9 (March 1998): 857-864.  Full Text
    • Madan, M, and Tcheng, JE. "Platelet Glycoprotein IIb/IIIa Integrin Blockade: Focus on Acute Myocardial Infarction." J Invasive Cardiol 10 Suppl A (March 1998): 27A-32A.  Link to Item
    • Kereiakes, DJ, Berkowitz, SD, Anderson, K, Simoons, M, Vahanian, A, Lincoff, AM, Tcheng, JE, Weisman, H, Califf, RM, and Topol, EJ. "Abciximab associated thrombocytopenia: Evidence for a complex interaction with heparin." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 31, no. 2 (February 1998): 55A-55A.  Full Text  Link to Item
    • Kereiakes, DJ, Lincoff, AM, Simoons, ML, deBoer, MJ, Tcheng, JE, Vahanian, A, Anderson, KM, Weisman, HF, Califf, RA, and Topol, EJ. "Complementarity of stenting and abciximab for percutaneous coronary intervention." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 31, no. 2 (February 1998): 54A-54A.  Full Text  Link to Item
    • Tcheng, JE, Kereiakes, DJ, George, BS, Braden, G, Langrall, MA, Zelinger, D, Jordan, R, and Effron, MB. "Safety of readministration of abciximab; Interim results of the ReoPro readministration registry (R-3)." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 31, no. 2 (February 1998): 55A-55A.  Full Text  Link to Item
    • Van Wart, S, Kosoglou, T, Tcheng, JE, Lorenz, T, Alton, K, Belanger, B, and Radwanski, E. "Eptifibatide pharmacokinetics in patients undergoing coronary angioplasty." CLINICAL PHARMACOLOGY & THERAPEUTICS 63, no. 2 (February 1998): 232-232.  Link to Item
    • Tcheng, JE. "Perspectives on the future of platelet glycoprotein IIb/IIIa blockade therapy." Tex Heart Inst J 25, no. 1 (1998): 49-56. (Review)  Link to Item
    • Berkowitz, SD, Harrington, RA, Rund, MM, and Tcheng, JE. "Acute profound thrombocytopenia after c7E3 fab therapy - Response." CIRCULATION 96, no. 10 (November 18, 1997): 3810-3810.  Link to Item
    • Aguirre, FV, Simoons, ML, Ferguson, JJ, Fitzpatrick, SE, Anderson, KM, Kern, MJ, and Tcheng, JE. "Impact of contrast media on clinical outcomes following percutaneous coronary interventions with platelet glycoprotein IIb/IIIa inhibition: Meta-analysis of clinical trials with abciximab." CIRCULATION 96, no. 8 (October 21, 1997): 898-898.  Link to Item
    • Blankenship, JC, Anderson, KM, Demko, SL, Lincoff, AM, Tcheng, JE, and Cabot, CF. "In-lab angiographic complications during coronary intervention with abciximab vs placebo in the EPILOG trial." CIRCULATION 96, no. 8 (October 21, 1997): 905-905.  Link to Item
    • Kereiakes, DJ, Lincoff, AM, Miller, DP, Tcheng, JE, Weisman, HF, and Topol, EJ. "Abciximab reduces risk of unplanned coronary stent deployment: Epilog trial results." CIRCULATION 96, no. 8 (October 21, 1997): 906-906.  Link to Item
    • Lincoff, AM, Tcheng, JE, Anderson, KM, and Cabot, CF. "Durable inhibition of ischemic complications by abciximab during percutaneous coronary revascularization: One-year results of the EPILOG trial." CIRCULATION 96, no. 8 (October 21, 1997): 902-902.  Link to Item
    • Madan, M, Kereiakes, DJ, Rund, M, Anderson, L, McDonald, MB, Tudor, G, Berkowitz, SD, Sketch, MH, Phillips, HR, and Tcheng, JE. "Abciximab readministration for coronary interventions: Is it safe?." CIRCULATION 96, no. 8 (October 21, 1997): 901-901.  Link to Item
    • Tcheng, JE. "Impact of eptifibatide on early ischemic events in acute ischemic coronary syndromes: a review of the IMPACT II trial. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis." Am J Cardiol 80, no. 4A (August 18, 1997): 21B-28B. (Review)  Link to Item
    • White, HD, Tcheng, JE, Harrington, RA, Phillips, D, and Kleiman, NS. "Roundtable panel discussion: The role of glycoprotein IIb-IIIa receptor inhibitors in acute ischemic coronary syndromes." AMERICAN JOURNAL OF CARDIOLOGY 80, no. 4A (August 18, 1997): B44-B48.  Link to Item
    • Topol, EJ, Ferguson, JJ, Weisman, HF, Tcheng, JE, Ellis, SG, Kleiman, NS, Ivanhoe, RJ, Wang, AL, Miller, DP, Anderson, KM, and Califf, RM. "Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication." Jama 278, no. 6 (August 13, 1997): 479-484.  Link to Item
    • Topol, EJ, Ferguson, JJ, Weisman, HF, Tcheng, JE, Ellis, SG, Kleiman, NS, Ivanhoe, RJ, Wang, AL, Miller, DP, Anderson, KM, and Califf, RM. "Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication." Jama 278, no. 6 (August 1997): 479-484.  Full Text
    • Tcheng, JE. "Platelet glycoprotein IIb/IIIa integrin blockade: recent clinical trials in interventional cardiology." Thrombosis and Haemostasis 78, no. 1 (July 1997): 205-209. (Review)
    • Topol, EJ, Califf, RM, Lincoff, AM, Tcheng, JE, Cabot, CF, Weisman, HF, Kereiakes, D, Lausten, D, Runyon, JP, Howard, W, Kelly, T, Muncy, D, Timmis, G, Safian, M, Davey, D, Kleiman, NS, Rose, D, Basinger, L, Rouse, C, Kramer, J, Wilson, R, Talley, JD, Boyles, M, Navetta, FI, LeBueuf, R, Kraft, P, Dvorak, L, Smigla, RM, Ferguson, J, Harlan, M, Browne, K, Telatnik, M, Blankenship, J, Demko, L, Ivanhoe, RJ, Jackson, C, Shadoff, N, Goebel, S, Taylor, M, Cleary, E, Gacioch, G, Chiodo, V, Bates, E, Quain, L, Snyder, H, Bass, TA, Rohman, C, Gradman, A, Boltey, L, Tannenbaum, M, Stengl, D, Gordon, P, Wright, N, Cummins, F, Nonnweiler, J, Aversano, T, Peltzer, L, Bear, P, Craig, MB, Hattel, L, Tooke, G, Anderson, HV, Weigelt, L, Hettleman, B, Kennedy, S, Teirstein, PS, Claire, D, Sarembock, I, Sayre, S, Davidson, CJ, Schaechter, A, Aguirre, F, Stonner, T, Azrin, M, Bodett, J, Barry, MB, Worley, S, Frey, LA, Spriggs, DJ, Wahl, SA, Weston, MW, Yedinak, K, George, B, Smith, D, Gilliland, C, Ricci, DR, Fox, R, Hartman, C, Lunow, S, Farah, T, Petruolo, S, Sander, G, Stevens, A, Delise, K, Reen, B, Whisnant, D, Henderson, L, Heuser, R, Swiderski, K, Kaluzniak, M, Larkin, T, Jackson, BJ, Popma, J, Prunka, N, Sanz, M, Mayer, D, Mackey, K, Burton, J, Hogg, N, Brown, R, Stevens, K, French, W, Wang, S, Adelman, AG, Foulger, V, Weber, S, Gottlieb, R, Lavoie, J, King, S, Frerichs, F, Hollywood, L, Ducas, J, Schick, U, Hochman, JS, Slater, J, Tormey, D, ONeill, BJ, Foshay, K, Fitzgerald, N, Cheung, PK, Bedard, D, Knudtson, ML, Galbraith, D, Watt, H, Samaha, J, Hamilton, B, Klein, LW, Hebson, L, Almond, D, White, J, Rosenberg, MJ, Teully, S, Unks, M, Rodgers, K, Faxon, D, Gore, J, Kelsey, S, Lee, K, Sane, D, Walters, L, Booth, J, Cannata, R, Castle, V, Cohen, H, DeLuca, S, Kutner, M, Knuth, T, McCollough, T, McPherson, J, Melton, J, Miller, D, Pulliam, M, Sapp, S, Sigmon, KN, Montague, E, Alexander, K, Augostini, R, Bajzer, C, Bart, B, Belli, G, Carlson, J, Challapalli, R, Crenshaw, B, Dawson, I, Dickey, A, Echols, A, Erickson, B, Fontana, MB, Ghaffari, S, Gordon, C, Granger, C, Grano, G, Grimm, R, Johnson, T, Juran, N, Kingsley, A, Kruse, K, Lauer, M, Mahaffey, K, Malone, K, Mark, D, Marwick, T, Migrino, R, Miller, J, Newby, K, Pace, C, Peterson, E, Rabbani, R, Ragan, J, Rimmerman, C, Rodkey, S, Savor, V, Shaw, WF, Sila, C, Silver, M, Tan, W, Tobiasz, D, Vandervoort, P, Wang, CW, Ward, C, Waters, J, Wiehle, D, Winchell, M, Underwood, D, Clemons, P, Heupler, S, Powers, J, Rubin, D, Sgarbossa, E, Steinhubl, S, Moliterno, D, Debowey, D, Balazs, E, Crowe, T, Ivanc, T, Ols, L, Poliszczuk, R, Vilsack, H, Witherspoon, B, DavidsonRay, L, Anderson, KM, Giel, KM, Musco, MH, and Stoner, GL. "Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization." New England Journal of Medicine 336, no. 24 (June 12, 1997): 1689-1696. (Academic Article)  Link to Item
    • Puma, JA, Sketch, MH, Tcheng, JE, Gardner, LH, Nelson, CL, Phillips, HR, Stack, RS, and Califf, RM. "The natural history of single-vessel chronic coronary occlusion: a 25-year experience." American Heart Journal 133, no. 4 (April 1997): 393-399.  Full Text
    • Berkowitz, SD, Harrington, RA, Rund, MM, and Tcheng, JE. "Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy." Circulation 95, no. 4 (February 18, 1997): 809-813.  Link to Item
    • Deckers, J, Califf, RM, Topol, EJ, Lincoff, AM, Tcheng, JE, and Simoons, ML. "Use of abciximab (ReoPro(R)) is not associated with an increase in the risk of stroke: Overview of three randomized trials." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1997): 97489-97489.  Link to Item
    • Ellis, S, Lincoff, AM, Tcheng, JE, Miller, DP, Booth, JE, Califf, RM, and Topol, E. "Is there a differential benefit of ReoPro during PTCA for patients with certain lesion types?." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1997): 8012-8012.  Link to Item
    • Krucoff, MW, Landis, DI, Green, CL, Loeffler, AK, Eisenstein, E, Moore, A, Tcheng, JE, Califf, RM, Mark, DB, Morris, KG, and Sketch, MH. "Upright posture with a flexible femoral sheath: Safety and cost results from 900 patients in the ''heads up'' trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1997): 9938-9938.  Link to Item
    • Lincoff, AM, Mark, DB, Califf, RM, Tcheng, JE, Ellis, SG, DavidsonRay, L, Anderson, KM, Stoner, GL, and Topol, EJ. "Economic assessment of platelet glycoprotein IIb/IIa receptor blockade during coronary intervention in the EPILOG trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1997): 97484-97484.  Link to Item
    • Lincoff, AM, Tcheng, JE, Califf, RM, Bass, T, Popma, JJ, Teirstein, PS, Kleiman, NS, Hattel, LJ, Anderson, HV, Ferguson, JJ, Cabot, CF, Anderson, KM, Berdan, LG, Musco, MH, Weisman, HF, and Topol, EJ. "Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators." The American Journal of Cardiology 79, no. 3 (February 1997): 286-291.  Full Text
    • Lincoff, AM, Tcheng, JE, Califf, RM, Cabot, CF, Miller, DP, Booth, JE, Montague, EA, Anderson, KM, and Topol, EJ. "Abciximab (c7E3 fab, ReoPro) with reduced heparin dosing during coronary intervention: Final results of the EPILOG trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1997): 7396-7396.  Link to Item
    • Tardiff, BE, Tcheng, JE, Peck, S, Lincoff, AM, Harrington, RA, Califf, RM, and Topol, EJ. "Bleeding with coronary artery bypass surgery (CABG) in patients treated with a platelet glycoprotein IIb/IIIa inhibitor." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1997): 52128-52128.  Link to Item
    • Tcheng, JE, Anderson, K, Tardiff, BE, Cabot, CF, Lincoff, AM, Califf, RM, and Topol, EJ. "Reducing the risk of percutaneous intervention after coronary bypass surgery: Beneficial effects of abciximab treatment." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1997): 7395-7395.  Link to Item
    • Tcheng, JE, Lincoff, AM, Miller, DP, Booth, JE, Rund, MM, Cabot, CF, Weisman, HF, Califf, RM, and Topol, EJ. "Benefits of abciximab accrue in the full spectrum of coronary interventional patients: Insights from the EPILOG trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1997): 9931-9931.  Link to Item
    • Thel, MC, Davidson, CJ, Aguirre, FV, Peck, SL, Tcheng, JE, Lincoff, AM, Topol, EJ, and Califf, RM. "What predicts contrast nephropathy after coronary intervention? Insights from the IMPACT II trial." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1997): 8210-8210.  Link to Item
    • Amsterdam, PB, and Tcheng, JE. "Platelet and thrombin inhibitors as adjuncts to thrombolytic therapy and percutaneous coronary interventions: A review." Journal of Interventional Cardiology 10, no. 4 (1997): 249-263.
    • Ferrari, E, Thiry, M, Touati, C, Gibelin, P, Baudouy, M, Berkowitz, SD, Harrington, RA, Rund, MM, and Tcheng, JE. "Acute profound thrombocytopenia after c7E3 Fab therapy [27] (multiple letters)." Circulation 96, no. 10 (1997): 3809-3810.
    • Jr, DRH, Mehta, S, George, CJ, Margolis, JR, Leon, MB, Isner, JM, Bittl, JA, III, SBK, Siegel, RM, Sketch, MH, Cowley, MJ, Roubin, GS, Brinker, JA, Overlie, PA, Tcheng, J, Sanborn, TA, and Litvack, F. "Excimer laser coronary angioplasty: The New Approaches to Coronary Intervention (NACI) experience." American Journal of Cardiology 80, no. 10 A (1997): 99K-105K.  Full Text
    • Tan, H-C, Harrington, RA, and Tcheng, JE. "Platelet glycoprotein IIb/IIIa integrin blockade in coronary artery disease: Current state of the art." Journal of Thrombosis and Thrombolysis 4, no. 3-4 (1997): 431-439.  Full Text
    • Tan, HC, Harrington, RA, and Tcheng, JE. "Platelet Glycoprotein IIb/IIIa Integrin Blockade in Coronary Artery Disease: Current State of the Art." J Thromb Thrombolysis 4, no. 3/4 (1997): 431-439.  Link to Item
    • Tcheng, JE. "Impact of entifibatide on early ischemic event in acute ischemic coronary syndromes: A review of the IMPACT II trial." American Journal of Cardiology 80, no. 4 A (1997): 21B-28B.  Full Text
    • Tcheng, JE. "Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II." Lancet 349, no. 9063 (1997): 1422-1428.  Full Text
    • White, HD, Tcheng, JE, Harrington, RA, Phillips, D, and Kleiman, NS. "Roundtable panel discussion: The role of glycoprotein IIb-IIIa receptor inhibitors in acute ischemic coronary syndromes." American Journal of Cardiology 80, no. 4 A (1997): 44B-48B.  Full Text
    • Berkowitz, SD, Harrington, RA, Rund, MM, and Tcheng, JE. "Acute profound thrombocytopenia following C7E3 FAB (abciximab) therapy." BLOOD 88, no. 10 (November 15, 1996): 2055-2055.  Link to Item
    • Aguirre, FV, Topol, EJ, Ferguson, JJ, Blankenship, JC, Gardner, LH, Caracciolo, EA, Donohue, TJ, Harrington, RA, and Tcheng, JE. "Effect of platelet glycoprotein (GP) IIb/IIIa antagonism with integrilin on activated clotting times during coronary interventions: Results from the IMPACT II trial." CIRCULATION 94, no. 8 (October 15, 1996): 1148-1148.  Link to Item
    • Blankenship, JC, Sigmon, KN, Tardiff, BE, Demko, SL, and Tcheng, JE. "Effect of glycoprotein IIb/IIIa receptor inhibition on specific in-lab complications of coronary intervention and resultant CKMB elevation in the IMPACT II trial." CIRCULATION 94, no. 8 (October 15, 1996): 1150-1150.  Link to Item
    • Ghaffari, S, Kereiakes, DJ, Kelly, T, Tcheng, JE, Timmis, GC, Miller, DP, and Lincoff, AM. "Platelet GP IIb/IIIa receptor blockade reduces ischemic complications in patients undergoing directional coronary atherectomy." CIRCULATION 94, no. 8 (October 15, 1996): 1154-1154.  Link to Item
    • Gilchrist, IC, Muhlestein, JB, Ivanhoe, RJ, Gardner, LH, and Tcheng, JE. "Does interventional volume or academic status affect outcome? Insights from the IMPACT-II trial." CIRCULATION 94, no. 8 (October 15, 1996): 1888-1888.  Link to Item
    • Lincoff, AM, Tcheng, JE, Miller, DP, Booth, JE, Montague, EA, and Topol, EJ. "Marked enhancement of clinical efficacy of platelet GP IIb/IIIa blockade with c7E3 fab (Abciximab) linked to reduction in bleeding complications: Outcome in the EPILOG and EPIC trials." CIRCULATION 94, no. 8 (October 15, 1996): 2185-2185.  Link to Item
    • Pracyk, JB, Wall, TC, Longabaugh, JP, Tice, FD, Hochrein, J, Cox, GC, Lee, KL, and Tcheng, JE. "Femoral vascular complications following coronary intervention: Is mechanical clamp hemostasis better than hand pressure?." CIRCULATION 94, no. 8 (October 15, 1996): 2197-2197.  Link to Item
    • Tan, HC, Sketch, MH, Tan, ME, Sng, LWS, Tcheng, JE, and Zidar, JP. "Is there an optimal treatment strategy for stent restenosis?." CIRCULATION 94, no. 8 (October 15, 1996): 522-522.  Link to Item
    • Tcheng, JE. "Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective." Am J Cardiol 78, no. 3A (August 14, 1996): 35-40. (Review)  Link to Item
    • Tcheng, JE. "Saline infusion in excimer laser coronary angioplasty." Semin Interv Cardiol 1, no. 2 (June 1996): 135-141. (Review)  Link to Item
    • Narins, CR, Hillegass, WB, Nelson, CL, Tcheng, JE, Harrington, RA, Phillips, HR, Stack, RS, and Califf, RM. "Relation between activated clotting time during angioplasty and abrupt closure." Circulation 93, no. 4 (February 1996): 667-671.  Full Text
    • Sambol, NC, Tcheng, JE, Kitt, M, and Lorenz, T. "Population pharmacokinetics (PK) and pharmacodynamics (PD) of integrelin, a platelet aggregation inhibitor." CLINICAL PHARMACOLOGY & THERAPEUTICS 59, no. 2 (February 1996): PI84-PI84.  Link to Item
    • TCHENG, J. "Glycoprotein IIb/IIIa receptor inhibitors : putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective." Am J Cardiol 78 (1996).  Full Text
    • Tcheng, JE. "Platelet Integrin Glycoprotein IIb/IIIa Inhibitors: Opportunities and Challenges." J Invasive Cardiol 8 Suppl B (1996): 8B-14B.  Link to Item
    • Tcheng, JE. "Glycoprotein IIb/IIIa receptor inhibitors: Putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective." American Journal of Cardiology 78, no. 3 A (1996): 35-40.
    • Bittl, JA, Brinker, JA, Sanborn, TA, Isner, JM, and Tcheng, JE. "The changing profile of patient selection, procedural techniques, and outcomes in excimer laser coronary angioplasty. Participating Investigators of the Percutaneous Excimer Laser Coronary Angioplasty Registry." J Interv Cardiol 8, no. 6 (December 1995): 653-660.  Link to Item
    • Harrington, RA, Kleiman, NS, Kottke-Marchant, K, Lincoff, AM, Tcheng, JE, Sigmon, KN, Joseph, D, Rios, G, Trainor, K, and Rose, D. "Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention." The American Journal of Cardiology 76, no. 17 (December 1995): 1222-1227.  Full Text
    • Califf, RM, Lincoff, AM, Tcheng, JE, and Topol, EJ. "An overview of the results of the EPIC trial." European Heart Journal 16 Suppl L (November 1995): 43-49.  Full Text
    • Ohman, EM, Harrington, RA, Lincoff, AM, Kitt, MM, Kleiman, NS, and Tcheng, JE. "Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor." Eur Heart J 16 Suppl L (November 1995): 50-55. (Review)  Link to Item
    • HARRINGTON, RA, OHMAN, EM, SIGMON, KN, KLEIMAN, NS, SCHULMAN, SP, KOTTKEMARCHANT, K, LINCOFF, AM, JOSEPH, D, PARKER, J, KITT, MM, and TCHENG, JE. "INTENSITY OF INHIBITION OF THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR DIFFERS AMONG DISEASE STATES." CIRCULATION 92, no. 8 (October 15, 1995): 2333-2333.  Link to Item
    • KRUSE, KR, TANGUAY, JF, ARMSTRONG, BA, GARDNER, LH, PHILLIPS, HR, SKETCH, MH, TCHENG, JE, ZIDAR, JP, and STACK, RS. "LONG-TERM SURVIVAL AFTER MYOCARDIAL-INFARCTION IN PATIENTS WITH MULTIVESSEL CORONARY-DISEASE - A COMPARISON OF INFARCT-RELATED ARTERY (IRA) REVASCULARIZATION VERSUS TOTAL REVASCULARIZATION (TR)." CIRCULATION 92, no. 8 (October 15, 1995): 356-356.  Link to Item
    • LINCOFF, AM, TCHENG, JE, ELLIS, SG, MOLITERNO, DJ, KITT, MM, DEBOWEY, D, and TOPOL, EJ. "RANDOMIZED TRIAL OF PLATELET GLYCOPROTEIN-IIB/GLYCOPROTEIN-IIIA INHIBITION WITH INTEGRELIN(TM) FOR PREVENTION OF RESTENOSIS FOLLOWING CORONARY INTERVENTION - THE IMPACT-II ANGIOGRAPHIC SUBSTUDY." CIRCULATION 92, no. 8 (October 15, 1995): 2905-2905.  Link to Item
    • TCHENG, JE, LINCOFF, AM, SIGMON, KN, KITT, MM, CALIFF, RM, and TOPOL, EJ. "PLATELET GLYCOPROTEIN-IIB/GLYCOPROTEIN-IIIA INHIBITION WITH INTEGRELIN(TM) DURING PERCUTANEOUS CORONARY INTERVENTION - THE IMPACT-II TRIAL." CIRCULATION 92, no. 8 (October 15, 1995): 2595-2595.  Link to Item
    • O'Malley, CM, Paulson, EK, Kliewer, MA, Tcheng, JE, Hertzberg, BS, and Carroll, BA. "Color Doppler sonographic appearance of patent needle tracts after femoral arterial catheterization." Radiology 197, no. 1 (October 1995): 163-165.  Full Text  Link to Item
    • Paulson, EK, Kliewer, MA, Hertzberg, BS, Tcheng, JE, McCann, RL, Bowie, JD, and Carroll, BA. "Ultrasonographically guided manual compression of femoral artery injuries." Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine 14, no. 9 (September 1995): 653-659.  Full Text
    • Tcheng, JE. "Enhancing safety and outcomes with the newer antithrombotic and antiplatelet agents." Am Heart J 130, no. 3 Pt 2 (September 1995): 673-679. (Review)  Link to Item
    • Strauss, BH, Natarajan, MK, Batchelor, WB, Yardley, DE, Bittl, JA, Sanborn, TA, Power, JA, Watson, LE, Moothart, R, and Tcheng, JE. "Early and late quantitative angiographic results of vein graft lesions treated by excimer laser with adjunctive balloon angioplasty." Circulation 92, no. 3 (August 1, 1995): 348-356.  Link to Item
    • Puma, JA, Sketch, MH, Tcheng, JE, Harrington, RA, Phillips, HR, Stack, RS, and Califf, RM. "Percutaneous revascularization of chronic coronary occlusions: an overview." Journal of the American College of Cardiology 26, no. 1 (July 1995): 1-11. (Review)  Full Text
    • Tcheng, JE, Harrington, RA, Kottke-Marchant, K, Kleiman, NS, Ellis, SG, Kereiakes, DJ, Mick, MJ, Navetta, FI, Smith, JE, and Worley, SJ. "Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators." Circulation 91, no. 8 (April 1995): 2151-2157.  Full Text
    • Bittl, JA, Brinker, JA, Sanborn, TA, Isner, JM, and Tcheng, JE. "The changing profile of patient selection, procedural techniques, and outcomes in excimer laser coronary angioplasty." Journal of Interventional Cardiology 8, no. 6 (1995): 653-660.
    • Crenshaw, BS, Harrington, RA, and Tcheng, JE. "Novel antiplatelet agents: The glycoprotein IIb/IIIa inhibitors." Expert Opinion on Investigational Drugs 4, no. 11 (1995): 1033-1044.
    • Tcheng, JE, Wells, LD, Phillips, HR, Deckelbaum, LI, and Golobic, RA. "Development of a new technique for reducing pressure pulse generation during 308-nm excimer laser coronary angioplasty." Catheterization and Cardiovascular Diagnosis 34, no. 1 (January 1995): 15-22.  Full Text
    • Tcheng, JE. "Key References: Antiplatelet Therapy as an Adjunct to Thrombolysis and Coronary Angioplasty." J Thromb Thrombolysis 1, no. 2 (1995): 213-216.  Link to Item
    • Tcheng, JE. "Enhancing safety and outcomes with the newer antithrombotic and antiplatelet agents." American Heart Journal 130, no. 3 PART 2 (1995): 673-679.  Full Text
    • Tcheng, JE. "Trials of interventional devices." Journal of Myocardial Ischemia 7, no. 5 (1995): 214-220.
    • KRUCOFF, MW, JONES, RH, OCONNOR, CM, CRATER, SW, GREEN, CL, HIGGINBOTHAM, MB, ZIDAR, JP, TCHENG, JE, STACK, RS, and CALIFF, RM. "THE HIGH-RISK MYOCARDIAL-ISCHEMIA TRIAL (HIRMIT) RANDOMIZED PILOT AND REGISTRY - 6 DAY, 6 WEEK, 6 MONTH AND 1 YEAR MORTALITY." CIRCULATION 90, no. 4 (October 1994): 334-334.  Link to Item
    • RUND, MM, SMITH, DD, DELUCA, SA, ROUSE, CL, SIGMON, KN, JURAN, NB, OBRIEN, M, and TCHENG, JE. "HEPARIN DURING CORONARY ANGIOPLASTY - ARE THERE ANY RULES." CIRCULATION 90, no. 4 (October 1994): 487-487.  Link to Item
    • Tcheng, JE, Ellis, SG, George, BS, Kereiakes, DJ, Kleiman, NS, Talley, JD, Wang, AL, Weisman, HF, Califf, RM, and Topol, EJ. "Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty." Circulation 90, no. 4 (October 1994): 1757-1764.  Full Text
    • Tcheng, JE, Ellis, SG, George, BS, Kereiakes, DJ, Kleiman, NS, Talley, JD, Wang, AL, Weisman, HF, Califf, RM, and Topol, EJ. "Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty." Circulation 90, no. 4 (October 1, 1994): 1757-1764.  Full Text
    • Tenaglia, AN, Fortin, DF, Califf, RM, Frid, DJ, Nelson, CL, Gardner, L, Miller, M, Navetta, FI, Smith, JE, and Tcheng, JE. "Predicting the risk of abrupt vessel closure after angioplasty in an individual patient." Journal of the American College of Cardiology 24, no. 4 (October 1994): 1004-1011.  Full Text
    • Bittl, JA, Sanborn, TA, Yardley, DE, Tcheng, JE, Isner, JM, Chokshi, SK, Strauss, BH, Abela, GS, Walter, PD, and Schmidhofer, M. "Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry." Am J Cardiol 74, no. 2 (July 15, 1994): 144-148.  Link to Item
    • BRODIE, BR, GRINES, CL, IVANHOE, R, KNOPF, W, TAYLOR, G, OKEEFE, J, WEINTRAUB, RA, BERDAN, LG, TCHENG, JE, WOODLIEF, LH, CALIFF, RM, and ONEILL, WW. "6-MONTH CLINICAL AND ANGIOGRAPHIC FOLLOW-UP AFTER DIRECT ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION - FINAL RESULTS FROM THE PRIMARY ANGIOPLASTY REGISTRY." Circulation 90, no. 1 (July 1, 1994): 156-162. (Academic Article)  Full Text  Link to Item
    • Brodie, BR, Grines, CL, Ivanhoe, R, Knopf, W, Taylor, G, O'Keefe, J, Weintraub, RA, Berdan, LG, Tcheng, JE, and Woodlief, LH. "Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Final results from the Primary Angioplasty Registry." Circulation 90, no. 1 (July 1994): 156-162.  Full Text
    • Baumbach, A, Bittl, JA, Fleck, E, Geschwind, HJ, Sanborn, TA, Tcheng, JE, and Karsch, KR. "Acute complications of excimer laser coronary angioplasty: a detailed analysis of multicenter results. Coinvestigators of the U.S. and European Percutaneous Excimer Laser Coronary Angioplasty (PELCA) Registries." J Am Coll Cardiol 23, no. 6 (May 1994): 1305-1313.  Link to Item
    • Mark, DB, Nelson, CL, Califf, RM, Harrell, FE, Lee, KL, Jones, RH, Fortin, DF, Stack, RS, Glower, DD, and Smith, LR. "Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty." Circulation 89, no. 5 (May 1994): 2015-2025.  Full Text
    • Arie, S, Tcheng, JE, Garcia, DP, Checchi, H, Horta, P, Esteves Filho, A, Souza, AN, de Brito Júnior, FS, Bellotti, G, and Pileggi, F. "[Laser coronary angioplasty. Critical analysis of the first patients]." Arq Bras Cardiol 62, no. 4 (April 1994): 225-232.  Link to Item
    • Arie, S, Tcheng, JE, Garcia, DP, Checchi, H, Horta, P, Esteves Filho, A, Souza, AN, de Brito Júnior, FS, Bellotti, G, and Pileggi, F. "Laser coronary angioplasty. Critical analysis of the first patients." Arquivos Brasileiros de Cardiologia 62, no. 4 (April 1, 1994): 225-232.
    • O'Neill, WW, Brodie, BR, Ivanhoe, R, Knopf, W, Taylor, G, O'Keefe, J, Grines, CL, Weintraub, R, Sickinger, BG, and Berdan, LG. "Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry)." The American Journal of Cardiology 73, no. 9 (April 1994): 627-634.  Full Text
    • Topol, EJ, Califf, RM, Weisman, HF, Ellis, SG, Tcheng, JE, Worley, S, Ivanhoe, R, George, BS, Fintel, D, and Weston, M. "Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators." Lancet (London, England) 343, no. 8902 (April 1994): 881-886.  Full Text
    • HARRINGTON, RA, MARCHANT, K, KLEIMAN, NS, LEIMBERGER, JD, TCHENG, JE, SIGMON, KN, SMITH, DD, KITT, M, TOPOL, EJ, and CALIFF, RM. "BLEEDING ASSOCIATED WITH USE OF A PLATELET GLYCOPROTEIN IIBIIA INHIBITOR DURING ROUTINE CORONARY ANGIOPLASTY - IS TOO MUCH HEPARIN THE CULPRIT." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (February 1994): A106-A106.  Link to Item
    • HARRINGTON, RA, MARCHANT, K, KLEIMAN, NS, SIGMON, KN, JOSEPH, D, PARKER, J, RIOS, G, TCHENG, JE, KITT, M, CALIFF, RM, and TOPOL, EJ. "IMMEDIATE, REVERSIBLE PLATELET-AGGREGATION INHIBITION IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (February 1994): A106-A106.  Link to Item
    • MUHLESTEIN, JB, SKETCH, MH, TENAGLIA, AN, ZIDAR, JP, FORTIN, DF, BOONE, TD, TCHENG, JE, PHILLIPS, HR, and STACK, RS. "DOES THE USE OF HIGH INFLATION PRESSURES ADVERSELY AFFECT THE ACUTE AND LONG-TERM OUTCOME OF CORONARY ANGIOPLASTY." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (February 1994): A352-A352.  Link to Item
    • PUMA, JA, SKETCH, MH, TCHENG, JE, GARDNER, LH, NELSON, CL, PHILLIPS, HR, STACK, RS, and CALIFF, RM. "CHRONIC TOTAL CORONARY-OCCLUSION OF AN ISOLATED VESSEL IN 891 PATIENTS OVER 24 YEARS - IS MEDICAL-MANAGEMENT AND ADEQUATE APPROACH." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (February 1994): A390-A390.  Link to Item
    • STRAUSS, BH, NATARAJAN, MK, BATCHELOR, WB, YARDLEY, DE, SANBOM, TA, POWER, JA, WATSON, LE, MOOTHART, R, TCHENG, JE, BITTL, JA, and CHISHOLM, RJ. "QUANTITATIVE ANGIOGRAPHIC ANALYSIS OF VEIN GRAFT LESIONS TREATED WITH EXCIMER-LASER ANGIOPLASTY - IMMEDIATE AND FOLLOW-UP RESULTS." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (February 1994): A449-A449.  Link to Item
    • Baumbach, A, Bittl, JA, Fleck, E, Geschwind, HJ, Sanborn, TA, Tcheng, JE, Arsch, KRK, and The, COTUS. "Acute complications of excimer laser coronary angioplasty: A detailed analysis of multicenter results." Journal of the American College of Cardiology 23, no. 6 (1994): 1305-1313.
    • Bittl, JA, Sanborn, TA, Yardley, DE, Tcheng, JE, Isner, JM, Chokshi, SK, Strauss, BH, Abela, GS, Walter, PD, Schmidhofer, M, Power, JA, and Registry, TPELCA. "Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions." The American Journal of Cardiology 74, no. 2 (1994): 144-148.  Full Text
    • KEREIAKES, D, FERGUSON, JJ, POPMA, JJ, SHAW, RE, TCHENG, JE, WEISMAN, H, LINCOFF, AM, BREZINA, K, and AGUIRRE, F. "UNTITLED." JOURNAL OF INVASIVE CARDIOLOGY 6 (1994): A43-A56.  Link to Item
    • TCHENG, J. "Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty." Circulation 90 (1994): 1757-1764.
    • Tcheng, JE. "Dosing and administration of ReoPro (c7E3 Fab)." J Invasive Cardiol 6 Suppl A (1994): 29A-33A. (Review)  Link to Item
    • BITTL, JA, SANBORN, TA, TCHENG, JE, and WATSON, LE. "EXCIMER LASER-FACILITATED ANGIOPLASTY FOR UNDILATABLE CORONARY LESIONS - RESULTS OF A PROSPECTIVE CONTROLLED-STUDY." CIRCULATION 88, no. 4 (October 1993): 24-24.  Link to Item
    • BITTL, JA, TCHENG, JE, and SANBORN, TA. "THE CHANGING PROFILE OF PATIENTS AND LESIONS TREATED WITH PERCUTANEOUS EXCIMER-LASER CORONARY ANGIOPLASTY - 1989 TO 1993." CIRCULATION 88, no. 4 (October 1993): 23-23.  Link to Item
    • HARRINGTON, RA, RIOS, G, KLEIMAN, NS, SIGMON, K, SANE, DC, TCHENG, JE, MERCADO, C, SWIFT, R, and KITT, M. "PLATELET-FUNCTION DURING INTEGRELIN ADMINISTRATION IN CORONARY ANGIOPLASTY." CIRCULATION 88, no. 4 (October 1993): 319-319.  Link to Item
    • RESAR, JR, BITTL, JA, TCHENG, JE, DECKELBAUM, LI, and BRINKER, JA. "PERCUTANEOUS EXCIMER-LASER CORONARY ANGIOPLASTY WITH ECCENTRIC MONORAIL CATHETERS." CIRCULATION 88, no. 4 (October 1993): 24-24.  Link to Item
    • TCHENG, JE, ELLIS, , KLEIMAN, NS, HARRINGTON, RA, MICK, MJ, NAVETTA, FI, WORLEY, S, SMITH, JE, KEREIAKES, DJ, KITT, MM, MILLER, JA, SIGMON, KN, CALIFF, RM, and TOPOL, EJ. "OUTCOME OF PATIENTS TREATED WITH THE GPIIB/IIIA INHIBITOR INTEGRELIN DURING CORONARY ANGIOPLASTY - RESULTS OF THE IMPACT STUDY." CIRCULATION 88, no. 4 (October 1993): 595-595.  Link to Item
    • TCHENG, JE, TOPOL, EJ, KLEIMAN, NS, ELLIS, SG, NAVETTA, FI, FINTEL, DJ, WEISMAN, HF, ANDERSON, K, WANG, AL, MILLER, JA, SIGMON, KN, and CALIFF, RM. "IMPROVEMENT IN CLINICAL OUTCOMES OF CORONARY ANGIOPLASTY BY TREATMENT WITH THE GPIIB/IIIA INHIBITOR CHIMERIC-7E3 - MULTIVARIABLE ANALYSIS OF THE EPIC STUDY." CIRCULATION 88, no. 4 (October 1993): 506-506.  Link to Item
    • Tenaglia, AN, Fortin, DF, Frid, DJ, Gardner, LH, Nelson, CL, Tcheng, JE, Stack, RS, and Califf, RM. "Long-term outcome following successful reopening of abrupt closure after coronary angioplasty." The American Journal of Cardiology 72, no. 1 (July 1993): 21-25.  Full Text
    • Tenaglia, AN, Zidar, JP, Jackman, JD, Fortin, DF, Krucoff, MW, Tcheng, JE, Phillips, HR, and Stack, RS. "Treatment of long coronary artery narrowings with long angioplasty balloon catheters." Am J Cardiol 71, no. 15 (June 1, 1993): 1274-1277.  Link to Item
    • Bittl, JA, Ryan, TJ, Keaney, JF, Tcheng, JE, Ellis, SG, Isner, JM, and Sanborn, TA. "Coronary artery perforation during excimer laser coronary angioplasty. The percutaneous Excimer Laser Coronary Angioplasty Registry." J Am Coll Cardiol 21, no. 5 (April 1993): 1158-1165.  Link to Item
    • Ellis, SG, Tcheng, JE, Navetta, FI, Muller, DW, Weisman, HF, Smith, C, Anderson, KM, Califf, RM, and Topol, EJ. "Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein IIb/IIIa in patients undergoing elective coronary angioplasty." Coronary Artery Disease 4, no. 2 (February 1993): 167-175.
    • Bittl, JA, Jr, TJR, Jr, JFK, Tcheng, JE, Ellis, SG, Isner, JM, and Sanborn, TA. "Coronary artery perforation during excimer laser coronary angioplasty." Journal of the American College of Cardiology 21, no. 5 (1993): 1158-1165.
    • Tcheng, JE, Jackman, JD, Califf, RM, and Stack, RS. "Managing myocardial infarction complicated by mitral regurgitation." Primary Cardiology 19, no. 10 (January 1, 1993): 40-48. (Review)
    • Tcheng, JE, Jackman, JD, Nelson, CL, Gardner, LH, Smith, LR, Rankin, JS, Califf, RM, and Stack, RS. "Does reperfusion improve prognosis when mitral regurgitation complicates infarction?." Cardiology Board Review 10, no. 8 (January 1, 1993): 17-22.
    • Bittl, JA, Sanborn, TA, Tcheng, JE, Siegel, RM, and Ellis, SG. "Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry." Am J Cardiol 70, no. 20 (December 15, 1992): 1533-1539.  Link to Item
    • BAUMBACH, A, BITTL, JA, FLECK, E, GESCHWIND, HJ, SANBORN, TA, TCHENG, JE, and KARSCH, KR. "ACUTE COMPLICATIONS OF CORONARY EXCIMER LASER ANGIOPLASTY - ANALYSIS OF 2 MULTICENTER REGISTRIES." CIRCULATION 86, no. 4 (October 1992): 510-510.  Link to Item
    • BITTL, JA, SANBORN, TA, TCHENG, JE, KEANEY, JF, ESTELLA, P, and RYAN, TJ. "RISK OF CORONARY-ARTERY PERFORATION DURING EXCIMER LASER ANGIOPLASTY." CIRCULATION 86, no. 4 (October 1992): 654-654.  Link to Item
    • ELLIS, SG, ARNOLD, AZ, RAYMOND, RE, EIGLER, NL, SANBORN, TA, BITTL, JA, LINCOFF, AM, MOONEY, MR, TCHENG, JE, and TOPOL, EJ. "INCREASED CORONARY PERFORATION IN THE NEW DEVICE ERA - INCIDENCE, CLASSIFICATION, MANAGEMENT AND OUTCOME." CIRCULATION 86, no. 4 (October 1992): 787-787.  Link to Item
    • TCHENG, JE, BITTL, JA, SANBORN, TA, SIEGEL, RM, GINSBURG, R, POWER, JA, COHEN, ED, BIDDLE, WP, and JACKMAN, JD. "TREATMENT OF AORTOOSTIAL DISEASE WITH PERCUTANEOUS EXCIMER LASER CORONARY ANGIOPLASTY." CIRCULATION 86, no. 4 (October 1992): 512-512.  Link to Item
    • TENAGLIA, AN, TCHENG, JE, KISSLO, KB, PEREZ, JA, PHILLIPS, HR, and DAVIDSON, CJ. "INTRACORONARY ULTRASOUND EVALUATION OF EXCIMER LASER ANGIOPLASTY." CIRCULATION 86, no. 4 (October 1992): 516-516.  Link to Item
    • Muhlestein, JB, Quigley, PJ, Ohman, EM, Bauman, RP, Sketch, MH, Tcheng, JE, Davidson, CJ, Peter, RH, Behar, VS, and Krucoff, MW. "Prospective analysis of possible myocardial damage or hemolysis occurring as a result of prolonged autoperfusion angioplasty in humans." J Am Coll Cardiol 20, no. 3 (September 1992): 594-598.  Link to Item
    • Tenaglia, AN, Quigley, PJ, Kereiakes, DJ, Abbottsmith, CW, Phillips, HR, Tcheng, JE, Rendall, D, and Ohman, EM. "Coronary angioplasty performed with gradual and prolonged inflation using a perfusion balloon catheter: procedural success and restenosis rate." Am Heart J 124, no. 3 (September 1992): 585-589.  Link to Item
    • Jackman, JD, Hermiller, JB, Sketch, MH, Davidson, CJ, Tcheng, JE, Phillips, HR, and Stack, RS. "Combined rotational and directional atherectomy guided by intravascular ultrasound in an occluded vein graft." Am Heart J 124, no. 1 (July 1992): 214-216.  Link to Item
    • Tcheng, JE, Jackman, JD, Nelson, CL, Gardner, LH, Smith, LR, Rankin, JS, Califf, RM, and Stack, RS. "Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction." Annals of Internal Medicine 117, no. 1 (July 1992): 18-24.  Full Text
    • Jackman, JD, Zidar, JP, Tcheng, JE, Overman, AB, Phillips, HR, and Stack, RS. "Outcome after prolonged balloon inflations of greater than 20 minutes for initially unsuccessful percutaneous transluminal coronary angioplasty." Am J Cardiol 69, no. 17 (June 1, 1992): 1417-1421.  Link to Item
    • Bittl, JA, Sanborn, TA, Tcheng, JE, Siegel, RM, Ellis, SG, and Registry, TPELCA. "Clinical success, complications and restenosis rates with excimer laser coronary angioplasty." The American Journal of Cardiology 70, no. 20 (1992): 1533-1539.  Full Text
    • TCHENG, JE. "Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction." Ann Intern Med 117 (1992): 18-24.
    • Tcheng, JE, Miller, JS, Songer, RW, and Golobic, RA. "Percutaneous excimer laser coronary angioplasty: development of technology and initial clinical results." Proceedings of SPIE - The International Society for Optical Engineering 1642 (1992): 98-109.
    • Davidson, CJ, Sheikh, KH, Kisslo, KB, Phillips, HR, Peter, RH, Behar, VS, Kong, YH, Krucoff, M, Ohman, EM, and Tcheng, JE. "Intracoronary ultrasound evaluation of interventional technologies." Am J Cardiol 68, no. 13 (November 15, 1991): 1305-1309.  Link to Item
    • Jackman, JD, Navetta, FI, Smith, JE, Tcheng, JE, Davidson, CJ, Phillips, HR, Califf, RM, Nelson, CL, Gardner, LH, and Stack, RS. "Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectoris." The American Journal of Cardiology 68, no. 1 (July 1991): 116-119.  Full Text
    • CALIFF, RM, FORTIN, DF, FRID, DJ, HARLAN, WR, OHMAN, EM, BENGTSON, JR, NELSON, CL, TCHENG, JE, MARK, DB, and STACK, RS. "RESTENOSIS AFTER CORONARY ANGIOPLASTY - AN OVERVIEW." Journal of the American College of Cardiology 17, no. 6 (May 1, 1991): B2-B13. (Review)  Link to Item
    • Califf, RM, Fortin, DF, Frid, DJ, Harlan, WR, Ohman, EM, Bengtson, JR, Nelson, CL, Tcheng, JE, Mark, DB, and Stack, RS. "Restenosis after coronary angioplasty: an overview." Journal of the American College of Cardiology 17, no. 6 Suppl B (May 1991): 2B-13B. (Review)  Full Text
    • Tenaglia, AN, Tcheng, JE, Phillips, HR, and Stack, RS. "Creation of pseudo narrowing during coronary angioplasty." Am J Cardiol 67, no. 7 (March 15, 1991): 658-659.  Link to Item
    • Cusma, JT, Spero, LA, Morris, KG, Tcheng, JE, and Bashore, TM. "Quantitative analysis of cardiac images: Application in the clinical environment." MedicaMundi 36, no. 1 (1991): 26-35.
    • FORTIN, DF, FRID, DJ, NELSON, C, SMITH, JE, RAMOS, RF, HARLAN, WR, and TCHENG, JE. "THE IMPACT OF GENDER AND MENOPAUSAL STATUS ON RESTENOSIS AFTER ANGIOPLASTY." CIRCULATION 82, no. 4 (October 1990): 624-624.  Link to Item
    • FRID, DJ, FORTIN, DF, LAM, LC, HARLAN, WR, NAVETTA, FI, SMITH, JE, RAMOS, R, NELSON, C, and TCHENG, JE. "EFFECTS OF UNSTABLE SYMPTOMS ON RESTENOSIS." CIRCULATION 82, no. 4 (October 1990): 427-427.  Link to Item
    • NELSON, CL, TCHENG, JE, FRID, DJ, FORTIN, DF, OHMAN, EM, CALIFF, RM, and STACK, RS. "INCOMPLETE ANGIOGRAPHIC FOLLOW-UP RESULTS IN SIGNIFICANT UNDERESTIMATION OF TRUE RESTENOSIS RATES AFTER PTCA." CIRCULATION 82, no. 4 (October 1990): 312-312.  Link to Item
    • SKETCH, MH, ONEILL, WW, TCHENG, JE, WALKER, C, GALICHIA, JP, SAWCHAK, S, CRESS, S, PHILLIPS, HR, and STACK, RS. "EARLY AND LATE OUTCOME FOLLOWING CORONARY TRANSLUMINAL EXTRACTION-ENDARTERECTOMY - A MULTICENTER EXPERIENCE." CIRCULATION 82, no. 4 (October 1990): 310-310.  Link to Item
    • SMITH, JE, NAVETTA, FI, GURBEL, PA, GARDNER, L, NELSON, C, HOFFMAN, P, RENDALL, D, and TCHENG, JE. "CAN INTRACORONARY UROKINASE SALVAGE VESSEL PATENCY AFTER FAILED INTRAVENOUS-TPA AND PREVENT THE NEED FOR RESCUE PTCA." CIRCULATION 82, no. 4 (October 1990): 537-537.  Link to Item
    • TCHENG, JE, FORTIN, DF, FRID, DJ, NELSON, CL, RENDALL, DS, LEE, KL, and STACK, RS. "CONDITIONAL PROBABILITIES OF RESTENOSIS FOLLOWING CORONARY ANGIOPLASTY." CIRCULATION 82, no. 4 (October 1990): 1-1.  Link to Item
    • TCHENG, JE, JACKMAN, JD, GARDNER, LH, NELSON, CL, BAUMAN, RP, SMITH, LR, and RANKIN, JS. "OPTIMIZATION OF LONG-TERM OUTCOME IN ACUTE MITRAL REGURGITATION DUE TO MYOCARDIAL-INFARCTION." CIRCULATION 82, no. 4 (October 1990): 511-511.  Link to Item
    • LUNDERGAN, CF, FOEGH, ML, QUIGLEY, P, TCHENG, JE, and RAMWELL, PW. "EFFECT OF ANGIOPEPTIN ON ATHEROGENESIS IN CYNOMOLGOUS MACAQUES." ARTERIOSCLEROSIS 10, no. 5 (1990): A815-A815.  Link to Item
    • STACK, RS, CALIFF, RM, PHILLIPS, HR, PRYOR, DB, QUIGLEY, PJ, BAUMAN, RP, TCHENG, JE, and GREENFIELD, JC. "INTERVENTIONAL CARDIAC-CATHETERIZATION AT DUKE-MEDICAL-CENTER." AMERICAN JOURNAL OF CARDIOLOGY 62, no. 10 (October 1, 1988): F3-F24.  Link to Item
    • Stack, RS, Califf, RM, Phillips, HR, Pryor, DB, Quigley, PJ, Bauman, RP, Tcheng, JE, and Greenfield, JC. "Interventional cardiac catheterization at Duke Medical Center." The American Journal of Cardiology 62, no. 10 Pt 2 (October 1988): 3F-24F. (Review)
    • Stack, RS, Califf, RM, Phillips, HR, Pryor, DB, Quigley, PJ, Bauman, RP, Tcheng, JE, and Greenfield, JC. "Interventional Cardiac Catheterization at Duke Medical Center - The Duke Interventional Cardiac Catheterization Program." American Journal of Cardiology 62, no. 10 PART II (January 1, 1988). (Review)
    • Stack, RS, Califf, RM, Phillips, HR, Pryor, DB, Quigley, PJ, Bauman, RP, Tcheng, JE, and Greenfield, JC. "New international technology: The autoperfusion balloon catheter." American Journal of Cardiology 62, no. 10 PART II (January 1, 1988).
    • Stack, RS, Califf, RM, Phillips, HR, Pryor, DB, Quigley, PJ, Bauman, RP, Tcheng, JE, and Greenfield, JC. "Limitations of balloon angioplasty: Possible causes of restenosis." American Journal of Cardiology 62, no. 10 PART II (January 1, 1988).
    • Stack, RS, Califf, RM, Phillips, HR, Pryor, DB, Quigley, PJ, Bauman, RP, Tcheng, JE, and Jr, JCG. "Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone." American Journal of Cardiology 62, no. 10 PART II (1988): 4F-4F.
    • Kunkel, TA, Tcheng, JE, and Meyer, RR. "Purification and properties of DNA polymerase-beta from guinea pig liver." Biochim Biophys Acta 520, no. 2 (September 27, 1978): 302-316.  Link to Item
    • Mosbaugh, DW, Kunkel, TA, Stalker, DM, Tcheng, JE, and Meyer, RR. "Novikoff hepatoma deoxyribonucleic acid polymerase. Sensitivity of the beta-polymerase to sulfhydryl blocking agents." Nucleic Acids Res 3, no. 9 (September 1976): 2341-2352.  Link to Item
• Scholarly, Clinical, & Service Activities
• 

  Service to the Profession

  • Chair. Informatics and Health IT Committee. American College of Cardiology. 1996  1996

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.